6,403 Matching Annotations
  1. Last 7 days
    1. On 2019-03-20 00:30:07, user Charles Warden wrote:

      I have not submitted something to F1000 Research myself, but I thought the article would be posted while you were awaiting reviewers.

      While I admittedly don't see a "pysradb" article in F1000 research, I thought it was a little strange for the bioRxiv pre-print to be formatted as a F1000 pre-submission. I know of one article that was submitted to PLOS ONE that automatically got deposited into bioRxiv, but I didn't think F1000 did something similar. Is there a reason this pre-print is formatted as a F1000 pre-submission?

    1. On 2013-11-13 19:03:07, user Mick Watson wrote:

      In terms of microarray and NGS data not being correlated for miRNA, this paper may be very relevant:

      http://www.ncbi.nlm.nih.gov...

      Sorefan K, Pais H, Hall AE, Kozomara A, Griffiths-Jones S, Moulton V, Dalmay<br /> T. (2012) Reducing ligation bias of small RNAs in libraries for next generation<br /> sequencing. Silence. 3(1):4.

      Proven bias in the measurement of miRNA by NGS.

    1. On 2024-05-01 23:23:51, user Guei-Sheung Liu wrote:

      The article has now publshed in Nucleic Acid Ther.<br /> An Integrative Multi-Omics Analysis Reveals MicroRNA-143 as a Potential Therapeutic to Attenuate Retinal Angiogenesis.<br /> Wang JH, Chuang YF, Chen J, Singh V, Lin FL, Wilson R, Tu L, Ma C, Wong RCB, Wang PY, Zhong J, Hewitt AW, van Wijngaarden P, Dusting GJ, Liu GS.<br /> Nucleic Acid Ther. 2022 Aug;32(4):251-266. doi: 10.1089/nat.2021.0111. Epub 2022 Mar 31. PMID: 35363088

    1. On 2020-03-22 10:20:55, user Yu Lan wrote:

      The HECs we identified showed unambiguous endothelial characteristics molecularly, functionally, and anatomically. Furthermore, the hematopoietic feature was largely ruled out as the HECs hardly generated CFU-Cs by directly cultured in methylcellulose culture medium. We have been aware of the potential low CD41 expression in HECs at both protein (by FACS antibody labelling) and transcriptional level. However, as Itga2b (encoding CD41) was ubiquitously low expressed in many embryonic ECs in addition to HECs at least transcriptionally, we did not consider the low expression of CD41 as a criterion of non-ECs. For the above reasons and from the view of vascular EC evolution, we prefer to name them as HECs but not pro-HSCs. Of note, the HECs we identified showed an obviously proliferative status whereas pro-HSCs are slowly cycling as reported. We are very pleased to directly and comprehensively compare the pro-HSCs and our HECs in the near future.

    1. On 2023-03-24 23:34:31, user Akshaya Jayakarunakaran wrote:

      Thank you so much for your paper. Therapeutics in relation to viruses is a personal favorite of mine and I found your paper to be extremely intriguing. I personally thought your mice work was great, and was a great model to be used. Additionally, the language employed by the paper was very easy to read and interpret. I do have a few suggestions:

      Personally, I found it a bit hard to read figure 5. So, I would encourage you to increase the size of the images. <br /> I would have also liked if separate data was included for mice of both sexes, so we could compare the effect that sex has. <br /> Figure 10 was also not great. I would have preferred a line graph to a bar graph or two bar graphs for each condition as opposed to stacked together.

      Overall, this was a great paper. Thank you for your work.

    1. On 2021-07-20 14:01:52, user Mel Symeonides wrote:

      (My peer review no longer appears because it was made on the first version of the article, and it unfortunately did not receive a response before the manuscript was updated. I am thus reposting it here on the second version, hoping for a response. The review is identical to the first one, apart from the comment on the new sequencing data.)

      With this study, Patterson et al. present a potentially very significant finding: that SARS-CoV-2 antigen persists in non-classical monocytes from Long COVID patients up to 15 months after the initial infection. The data supporting this finding are of moderate to low strength, as presented, primarily due to a wide range of major and minor presentation issues that are listed below. Most of these can be addressed easily, though it is unclear if some additional controls may be required. Finally, some orthogonal approaches are suggested that could be potentially very valuable in terms of increasing confidence in the findings (namely microscopy and immunoblotting), though these are not essential for the interpretation of the results as shown.

      The authors are to be commended for tackling Long COVID head-on and getting right to the heart of the matter in terms of finding the pathological cause of this disease. That said, unfortunately, this manuscript requires considerable revision in order to be interpretable and allow others to reproduce the findings (which will be of critical importance, given their potential significance).

      Major issues:

      • Table 1 and the accompanying text seems to indicate that PBMCs were tested for the presence of viral RNA by ddPCR. However, in the Material/Methods section, it is stated that nucleic acids were extracted from plasma, not from PBMCs. Please clarify this point as it is of critical relevance. Indeed, both plasma and PBMCs should have been individually tested in order to determine whether viral RNA was solely intracellular.

      • It is very unclear what Figure 2 is presenting. Presumably each row represents a different subject, but it is not denoted which subject belongs to which group, making intepretation very difficult. I presume this was an ommission.

      • Supplementary Table 1 was not provided, making it very difficult to evaluate the flow cytometry data. Even if that table were present, the methods provided for flow cytometry are very sparse. What steps were undertaken to establish the specificity of the Spike antibody? Was the Spike staining done after fixation and permeabilization? Was PE conjugation of this antibody done in-house, and if so, using which kit, and how was it verified that the conjugation and quenching were successful and that staining was specific within the context of the entire antibody panel? Were FMO controls done in the context of this new panel that includes the S1 antibody? Was Fc block included? etc.

      • The newly-added sequencing data are difficult to interpret. It seems that the authors interpret the poor sequence coverage as indicative of non-replicating virus and in line with high Ct values, yet they do not seem to comment on the fact that there is nevertheless some seemingly full-length viral genome present in these cells! This is a potentially very important finding and its source will need to be investigated. Additionally, the sequencing results are inconsistent with the PBMC RT-PCR results, where only LH5 was positive, yet LH1-5 all had similar sequence coverage. The names of the samples in Table 2 do not correspond to any other name in this manuscript, clearly they were not renamed as they should have been. In fact, some of these sample names look curiously like name initials, which is a potential study subject data privacy issue. Finally, it does not seem that any healthy controls or previous COVID/non-LH subjects were tested in the same manner, which would be very valuable information.

      • In general, the Figure Legends are very sparse and should be much more descriptive.

      Minor/moderate issues:

      • Table 1 shows that one of the study subjects was asymptomatic. Where is this subject grouped in the subsequent analysis? ALso, "NS" is not defined, presumably it means "nasopharyngeal swab"?

      • In Figure 2, left column, the CD14/CD16 gates shown were not applied equally from sample to sample. Furthermore, in the middle column it looks like S1+ non-classical cells tend to have a low-SSC profile, while S1- cells have a high-SSC profile that clusters together with intermediate cells. This suggests that the intermediate/non-classical discriminating gates may not have been set appropriately.

      • The quantification shown in the middle column of Figure 2 is labeled "CD16+CD14+COVIDS1+", however no "CD16+CD14+" subset is defined. Presumably the authors refer to the aggregate of the "CD14++CD16+" intermediate and "CD14loCD16+" non-classical subsets. This should be clearly stated as it makes interpretation of the data shown very difficult. Additionally, the quantification is based on the aggregate population, whereas based on the color coding, one would expect individual quantification for each subset. Given the relatively very minor contribution of the intermediate subset to the observed Spike S1 signal, it is unclear why this was included at all in this plot - why not just show the non-classical subset and base the quantification solely based on that, or alternatively, show quantification of each subset rather than their aggregate?

      • The labeling in Figure 3 could be better, the angled X axis labels are very difficult to follow. Maybe just indicate the monocyte subset as a title above each plot, and/or label each plot as a subfigure?

      • No information is provided on the statistical analyses done.

      • I did not look into all the cited work, but in one case (ref. no. 19) was puzzled to see that a review article was cited in which the relevant information was in turn derived from a single primary research article. Surely it makes more sense to just cite that primary research paper rather than the review?

      General comments:

      • Why was S1 the only SARS-CoV-2 antigen stained for? One would expect that you would have quickly tried to look for other viral antigens, particularly Nucleocapsid, in order to begin to understand whether there might be virus particles present, especially since you found viral RNA in some samples. Additionally, some microscopy data on sorted non-classical monocytes would have been very valuable to validate what you see by flow cytometry, also because one could then evaluate whether the Spike signal in these cells looks like the expected pattern for protein being actively synthesized by the cell and present on the cell surface, or whether it is captured antigen from some site of viral persistence and is sequestered in some intracellular compartment. Finally, a Western blot for Spike (and other viral antigens) in flow-sorted monocytes would be of immense value to further validate the presence of this antigen and observe the state of the protein - indeed, it is rather odd that you seemingly went for LCMS before trying either microscopy or a Western blot!

      • The potential connections with the CX3CL1 pathway mentioned in Discussion are very interesting. Unfortunately, the authors have not demonstrated any elevation of CX3CL1 associated with severe acute COVID or long COVID disease, nor the presence of CX3CR1 on the particular cells of interest. If such data exist, please present them, otherwise this Discussion is rather speculative and much more work will be required to frame it in the appropriate context for a primary research paper. Alternatively, this discussion might be better suited for a separate Review article.

      • Much of the published work on Long COVID and other post-COVID conditions such as MIS-C is omitted here, and should be cited and discussed as appropriate.

      Mel Symeonides, Ph.D.<br /> Postdoctoral Associate<br /> Department of Microbiology & Molecular Genetics<br /> University of Vermont<br /> Burlington, VT

    1. On 2017-11-14 16:24:02, user Michel Renou wrote:

      Intereresting paper emphasizing the importance of visual cues in wind tunnel experiments and for the proper interpretation of insect flight tracks recorded in response to odors.<br /> Wondering however wether visual cues in these experiments are landing cues with low orientation value rather than contributing to orientation. I am not convinced by your conclusion "odour resolution is vision dependent". Seems to me that flies are raher good in finding the odorized pole in the experiment described on figure 6 (see 6A and 6B).

    1. On 2024-03-17 18:53:29, user Tibor Rohacs wrote:

      Cool new structures. It is interesting that DiC8 PIP2 can bind to the same site as the endogenous PI (and capsaicin), and results in a partially open state, potentially explaining the positive effects of DiC8 PIP2 in excised patches.

      What the paper does not mention is that long-acyl-chain natural PIP2 (PMID: 17596456, 24158445) and diplmitoyl PIP2 (PMID: 17074976) also potentiate TRPV1 in excised patches. This happens in the presence of capsaicin, which is hard to reconcile capsaicin and PIP2 acting on the same binding site.

      DiC8 PIP2 binding to the vanilloid (capsaicin) site also does not explain the finding that capsaicin induces a left-shift in the dose-response of DiC8 PIP2 activation of TRPV1 in excised patch experiments (PMID: 17596456: Fig 9), begging the question, where PIP2 bind to the channel in the presence of Capsaicin.

    1. On 2023-02-06 22:17:47, user Fraser Lab wrote:

      The following is an anonymous review, edited by James Fraser, that is largely concordant with the reviews of this manuscript posted by eLife. James is posting it on behalf of the author (who wishes to remain anonymous) to provide additional background context on the issue of how Orf3a could be misidentified as an ion channel.

      This paper is welcome because the biophysical aspects of previous viroporin work are problematic. The virology and other aspects of those works are presumably technically correct. But this speaks to the problems of silos, and that at some point virology and biophysics really need to sit down and have a talk.

      Below, I highlight how the papers from the virology labs are weak in the biophysical aspects. Consequently, the field is replete with exceedingly poorly executed and reviewed biophysics work that has proven to be irreproducible. A nice review (https://pubmed.ncbi.nlm.nih... "https://pubmed.ncbi.nlm.nih.gov/33154751/)") by Colin Nichols and Conor McClenaghan outlines the problems with the interpretations in previous work using bilayers, oocytes or mammalian cells.

      This paper by Miller/Clapham sets the record straight with regard to SARS CoV 2 protein 3a. It builds on Steve Grant in Henry Lester's lab at Caltech work (https://pubmed.ncbi.nlm.nih... "https://pubmed.ncbi.nlm.nih.gov/34197807/)"), which has shown that there is no evidence for 3a forming functional channels in oocyte plasma membranes. The Grant/Lester paper did a nice control using Spike and nsp2, which have never been claimed to have ion channel activity.

      These papers are necessary because of previous, poor-quality papers, which claimed channel activity. For example, Toft-Bertelsen et al. (https://www.ncbi.nlm.nih.go... "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636635/)") suggested that 3a was an ion channel. This paper claimed that numerous other viral accessory proteins - 7 or 8 of them also acted as ion channels, which prompted some skepticism in the field. That paper lacked important controls (e.g. no controls for proteins known not to be an ion channel, like Spike as done in the Grant/Lester paper). The major issue is that it was not properly controlled for the issue of endogenous background channels, sadly ( which is should be pointed out by reviewers as electrophysiology 101).

      Importantly, the Toft-Bertelsen work didn't even demonstrate that the proteins were in the plasma membrane. Without engineering the expression construct, it is almost certainly all in the ER-Golgi intermediate compartment, ERGIC). Sixteen biophysicists recently commented in Communications Biology (https://www.nature.com/arti... "https://www.nature.com/articles/s42003-022-03669-2)") on the shortcomings of the Todt-Bertelsen paper, explained several possible sources of artifact, and outlined experimental steps that could be followed to claim ion channel function.

      There are also papers on the E and 3a proteins that use only bilayer recordings. Two papers on SARS-CoV-1 from the Enjaunes lab show channel records that are scaled multiples of one another. In other words, the E channel (Figure 3a of Verdia-Baguena https://www.ncbi.nlm.nih.go... ) and the 3a channels (Figure 3 of Castaño-Rodriguez https://www.ncbi.nlm.nih.go... ) appear to be exact scaled copies of the same trace. This example has no rational explanation, but it is illustrative of the problems in the field. It doesn't reflect well on the reviewers and editors of those papers.

      An example of the steps for Ion channel function being met is observed for the E protein, which is likely to be a channel similar to the M2 of influenza (https://www.ncbi.nlm.nih.go... "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8251088/pdf/TJP-599-2851.pdf)"). Problematic aspects of other previous studies contrasting E and 3a are also reviewed here: https://www.ncbi.nlm.nih.go... .

      The structure of Orf3a is described by Kern et al (https://www.nature.com/arti... "https://www.nature.com/articles/s41594-021-00619-0)"). Key evidence for the channel function is provided by its sensitivity to ruthenium red, which blocks quite a few ubiquitous channels including those found in intracellular organelles. This results provide the main reason for skepticism of an Orf3a-specific result for this due to the high protein ratios. It is possible this is real, but it is unproven. One should keep in mind that ions can get across membranes in multiple ways, so this doesn't have to be by conduction?

      The current Miller et al manuscript (https://www.biorxiv.org/con...<br /> ) argues strongly against Orf3a channel function and provides an explanation for the results in Kern et al. Miller et al, only saw channels in proteoliposome patch-clamp recordings under the highest protein conditions used. These channel recordings were sensitive to DIDS and therefore likely to be due to contamination by VDAC or something similar.

    1. On 2019-12-19 02:09:02, user spiro p wrote:

      In our 2019 reply to Richiardi et al. 2017 (see https://doi.org/10.1101/201... "https://doi.org/10.1101/2019.12.09.869412)"), we report results from comprehensive experiments comparing the effects of spatial proximity (contiguous cluster size) vs. rsfMRI networks on false positive rates for significant strength fractions (SF) among simulated ‘noise’ networks with edge distributions similar to rsfMRI networks. Results show that significant SF is influenced only by cluster size, not by rsfMRI samples, and we conclude that significant SF is unrelated to rsfMRI networks. We also discuss why distance corrections and external face validity are not sufficient to establish internal validity of relationships between correlated gene expression and rsfMRI networks, and propose more rigorous approaches to preclude common pitfalls in related studies.

    1. On 2020-10-05 19:44:46, user Dmytro V. Gospodaryov wrote:

      It was believed that tardigrades did not have either alternative oxidase (AOX) or NADH dehydrogenase (NDH). At least, numerous database searches did not reveal any of these enzymes in sequenced tardigrade genomes. On the other hand, if we were right in our hypotheses expressed in our recent paper https://www.sciencedirect.c... , it would be logical for tardigrades to have an alternative respiratory chain enzyme. These animals may undergo hypoxia/re-oxygenation when fall into cryptobiosis during water deficit and recover after wetting, respectively. The research of Wojciechowska and colleagues is an important note in proof to our assumptions, as well as a considerable insight into the evolution of respiratory chains and the role of its alternative components in adaption of animals to the conditions that compromise proper operation of mitochondrial respiratory chain.

    1. On 2019-04-29 15:01:23, user xbdr86 wrote:

      Paper already published.

      Bofill-De Ros X, Kasprzak WK, Bhandari Y, Fan L, Cavanaugh Q, Jiang M, Dai L, <br /> Yang A, Shao TJ, Shapiro BA, Wang YX, Gu S. Structural Differences between<br /> Pri-miRNA Paralogs Promote Alternative Drosha Cleavage and Expand Target<br /> Repertoires. Cell Rep. 2019 Jan 8;26(2):447-459.e4. doi:<br /> 10.1016/j.celrep.2018.12.054. PubMed PMID: 30625327; PubMed Central PMCID:<br /> PMC6369706.

      https://www.cell.com/cell-reports/pdfExtended/S2211-1247(18)31984-3

    1. On 2020-04-09 17:50:06, user ZephirAWT wrote:

      This study used flawed allometric scaling with body surface area and administered lethal doses of each compound to the mice. This had nothing to do with any supposed drug interaction. The LD50 for metformin in mice via ip administration is 247 mg/kg (they gave them 250 mg/kg) and for CQ it is 66 mg/kg (they gave them 60 mg/kg). These doses are not equivalent to the therapeutic doses that humans use (5 mg/kg) that it shouldn’t come as a surprise that these mice died.

      And guess what? Just a few months before coronavirus outbreak hydroxychloroquine did show an excellent results just for prophylaxis of diabetes - actually much better than many super-duper modern (and expensive) drugs, like Canagliflozinfrom SGLT2 group of antidiabetics. So I wouldn't definitely take hydroxychloroquine interaction with metformin way too seriously. After all, we have fifty years experience with hydroxychloroquine and nobody still raised connection of adverse effects with diabetes lethality the less, whereas world is full of diabetes - which speaks for something.

    2. On 2020-04-10 02:14:31, user Brian Hanley wrote:

      I talked to a colleague who runs an ER in South Texas. He says, "Lots of data on patients in this area on plaquenil and metformin." He says it's obvious this does not happen in humans. Not at doses used in medicine. Another example of mouse model not corresponding to human model.

    1. On 2020-03-07 16:02:19, user ani1977 wrote:

      I was looking into this Spike glycoprotein (sp|P0DTC2) sequence in pre-release proteome of 2019-nCoV Wuhan Coronavirus [1] . This sequence when aligned with BLAST against nucleotide database NCBI [2] shows a peptide insert PRRA with respect to Bat coronavirus RaTG13 [3]. Further, the last couple of residues in this insert appear as IL and and VL in Bat SARS-like coronavirus [4] and Recombinant coronavirus clone [5] respectively. However, the SARS coronavirus https://www.ncbi.nlm.nih.go... has either LL ending or completely missing this peptide as in https://www.ncbi.nlm.nih.go... GDH-BJH01, so is this the "furin cleavage site"?

      [1] 2019-nCoV Wuhan Coronavirus protein sequences, (n.d.). ftp://ftp.uniprot.org/pub/d... (accessed March 7, 2020).<br /> [2] S.F. Altschul, W. Gish, W. Miller, E.W. Myers, D.J. Lipman, Basic local alignment search tool, J. Mol. Biol. 215 (1990) 403–410. https://doi.org/10.1006/jmb....<br /> [3] Bat coronavirus RaTG13, complete genome - Nucleotide - NCBI, (n.d.). https://www.ncbi.nlm.nih.go... (accessed March 7, 2020).<br /> [4] D. Hu, C. Zhu, L. Ai, T. He, Y. Wang, F. Ye, L. Yang, C. Ding, X. Zhu, R. Lv, J. Zhu, B. Hassan, Y. Feng, W. Tan, C. Wang, Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats, Emerg. Microbes Infect. 7 (2018) 154. https://doi.org/10.1038/s41....<br /> [5] M.M. Becker, R.L. Graham, E.F. Donaldson, B. Rockx, A.C. Sims, T. Sheahan, R.J. Pickles, D. Corti, R.E. Johnston, R.S. Baric, M.R. Denison, Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice, Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 19944–19949. https://doi.org/10.1073/pna....

    1. On 2021-12-22 13:24:15, user Jérôme Lannes wrote:

      proyecto muy interesante very interesting project! some people say "the gonadotropic endocrine cell is ultimately a neuron like any other" ????. in it turns out that a large number of perform involved in AD have been involved in the regulation of nsu2 and its activity Lannes J, et al. Sci Rep. 2016. PMID: 27703237

    1. On 2022-08-31 20:38:36, user Bob Renthal wrote:

      This paper is a superb addition to the quest for understanding of insect OR selectivity. The subtle increases or decreases in binding pocket volume introduced by Walter Leal and his coworkers using mutagenesis show dramatic changes in ion channel function. Whether the functional changes are caused by changes in ligand affinity within the binding site, or by changes in access to the occluded site (see https://doi.org/10.1016/j.b... "https://doi.org/10.1016/j.bpc.2022.106862)"), or by changes in coupling of binding to ion channel gating will undoubtedly be the subject of future studies on these ORs.

    1. On 2018-03-02 21:42:01, user Brice Vallieres wrote:

      Great initiative. For those looking to dive into the ct.gov data, we've released it in excel or csv form via https://trialtap.com. For sponsors our there, we also have a time tracker that reminds you when a study may be due based on the primary completion date and any certified delayed results posting. Subscribe to any study you'd like. Better to be proactive then end up on http://fdaaa.trialstracker....

    1. On 2017-06-30 00:16:52, user George wrote:

      To put this into perspective, is it still reasonable to think that adiposity (which elevates fasting insulin once it raises FFA levels) and NAFLD (which elevates fasting insulin by impairing insulin clearance) are still preceded by elevated postprandial insulin, for example as determined by a 2-hour OGTT insulin level?

    1. On 2019-11-19 11:28:15, user Thomas Blankers wrote:

      Dear authors,

      we enjoyed reading this preprint in our journal club. This is very interesting research and the finding that the genetic architecture of intra-individual variability in behaviors may be largely uncoupled from that of inter-individual variability in individual means, is fascinating. As even the phenotypic side of intra-individual variability is poorly studied, we felt like this section would benefit from some more elaboration of expectations and observations. For example, even though you state “cross-test correlations demonstrate that individuals show consistency in their level of behavioral predictability both within and across test-type”, the magnitude of the two correlations across testing paradigms are very low and only borderline significant (in a sea of highly significant within-testing paradigm correlations). My naïve expectations would be more and stronger coupling across tests, but I guess that depends on many factors.

      It is also unclear how the phenotypic correlations and their sources of error would shape the coupling of genetic architectures of intra-individual trait variability in different test paradigms (QTL for IVV traits same to only occasionally overlap between testing paradigms). We felt like a somewhat broader introduction to the different forms of intra-individual variability and which ones specifically you are addressing here, the null expectations for how consistent these behaviors ought to be across testing paradigms, and which scenarios would result in more or less overlap among QTL (both overlap between means and IVV and between IVV testing paradigms) would help guide the reader a lot.

      To illustrate what I mean: Looking at figure 2, the two chromosomes where QTL for inter and intra-individual variability overlapped (10 and 24), were also chromosomes where IVV measured under different paradigms overlapped, whereas most of the other QTL did not overlap. So, what does a unique genetic architecture for inter and intra-individual variation mean when there is also limited overlap between different experiments for the same behavior? And the overlapping QTL for IVV and QTL for means seem to have small confidence regions, so maybe these are also the QTL of high effect? This prompts the question: How much of the variance is explained by shared versus unique QTL? And, what would be a reasonable expectation under different true distributions of causal loci? All these questions are likely to be answered when the context of intra-individual variability, the expectations as to how much of the genetic bases explored here should be shared, and what the observed amount of sharing/independence means biologically are more clearly outlined in the introduction and discussion. Best of luck and please do not hesitate to contact me if you have any questions.

    1. On 2019-08-26 07:21:35, user Midhun K Madhu wrote:

      Hi,

      This is just a comment about the introduction part of the article. In page 4 bottom, it is written that,

      “The negative charge in PG molecules favored interaction with positively-charged residues in the intracellular loop 3 (ICL3) and intracellular end of transmembrane helix 6 (TM6). This stabilized the outward movement of TM6 and hence the active state of the b2AR.”

      I wonder how that matches with the first sentence of page 5:

      “In contrast, lipids with negatively-charged PE headgroup formed favorable interactions with the positively-charged residues in the TM6 and stabilized active state of the b2AR”

      Overall head group of PE is neutral and hence the said negative-positive interaction with protein may be unfavorable. Although both sentences convey that the active state is stabilized, the start of the latter sentence suggests that the authors want to give something opposite in the 2nd sentence.

      Please consider this as a confusion while reading.

    1. On 2018-11-14 16:34:20, user Yuji Kondo wrote:

      Dear author. Thanks for exciting paper. I have a question about figure 1F especially nuclear lamina and nuclear pore. What do you think about overall nuclear staining even in limited expression of APEX2 in nuclear lamina or pore? I am a bit confused with mis-match of co-staining of avidin and APEX2. I want to hear your thought. Thank you so much in advance.

    1. On 2018-08-02 05:42:33, user Simon Sadedin wrote:

      Congratulations on the manuscript and the work in producing SciPipe!

      As the author of Bpipe, however, I feel I ought to clarify a couple of things mentioned in the manuscript: Bpipe definitely allows you to define the names of output files however you like. Also, Bpipe supports some forms of dynamic scheduling - for example, computational resources, number of parallel paths to split on in scatter-gather parallelism, even if-then type logic to choose which paths are executed can all be decided dynamically during execution.

    1. On 2017-11-22 22:38:27, user SC4649 wrote:

      L141-144: 'However, an important part of this story is often missed: Felsenstein also noted that the problem of non-independence does not occur if “characters respond essentially instantaneously to natural selection in the current environment, so that phylogenetic inertia is essentially absent” (p. 6).'

      ...Felsenstein (1985) followed this passage with:

      'It may be doubted how often phylogenetic inertia is effectively absent. In any case the presumption of the absence of phylogenetic inertia should be acknowledged whenever it is proposed to do comparative studies without taking account of phylogeny.'

      Basically, Felsenstein said that phylogenetic inertia should be expected in most cases, and you ought to state your presumptions for its absence if you're going to do non-phylo study.

      So I don't think Felsenstein's quote is used appropriately here...

    1. On 2020-06-22 18:59:35, user Donald R. Forsdyke wrote:

      FUNCTIONAL BASIS FOR PERVASIVE RNA SECONDARY STRUCTURE

      .<br /> The author and his colleagues have studied the genomes of both hepatitis C viruses (1) and coronaviruses (2). They note for single strands of RNA genomes that “structural configuration is dependent on both the order of bases and the G+C content of the sequence” (1). They estimate the “sequence order component of RNA structure” by “comparison of minimum folding energies (MFEs) of native sequences with those of the same sequence scrambled in base order” (1). Thus, “subtraction of the mean shuffled sequence MFE from the native MFE yielded an MFE difference (MFED) that represent the primary metric for quantifying RNA structure” (2). In the 1990s this was referred to as “folding of randomized sequence difference” (FORS-D) analysis and was applied both to eukaryotic genes (3, 4) and to viral genomes (5). Here it is referred to as “genome-scale ordered RNA structure” (GORS) analysis. <br /> .

      When comparing different viral isolates, the authors note that usage of synonymous codons often allows a protein sequence to remain functionally constant while affording flexibility to<br /> the structure of the encoding RNA. Yet GORS analysis “reveals many differences from the better characterised discrete elements of folded RNA found in RNA virus genomes” (1). Such structures tend to serve local functions (e.g. replication initiation, ribosomal interactions, translation initiation, RNAseL susceptibility) and are conserved between different isolates. <br /> .

      Since “MFED values greater than zero were observed throughout the genomes of each genotype analysed,” GORS is considered “pervasive throughout the genome” (1). This is held to “challenge the prevailing paradigm of viral structures being discrete elements”<br /> (1). Thus, it is regretted that “the functional basis for the adoption of pervasive RNA secondary structure is unknown” (2), and “the broader underlying reasons for virus genomes becoming structured in this way require considerable further investigation” (1). However, the “endeavour to understand its biological purpose” (2) began in the 1990s (3-5).<br /> .

      Explanations in terms of genome repair mechanisms and speciation have a considerable literature that is listed elsewhere (6). For the evolution of hepatitis C viruses, where “structural conservation was evident at subtype level only” (1), the globally “substantial<br /> degree of RNA structure re-invention” found in each subtype should signify the emergence of reproductive isolation barriers that could facilitate its persistence in a common host species, while enhancing possibilities of evolution into distinct viral species (6).<br /> .

      Coronaviruses having globally even greater MFEDs than hepatitis C viruses (2), then pressures for persistence would seem much greater. An impairment of “kissing” loop interactions between co-infecting subtypes would favor subtype persistence (by excluding recombinational blending). Greater variation in loops than in stems (2) would be consistent<br /> with this. Since the base order-dependent folding components (FORS-D, MFED) are<br /> derived by subtraction, values of base composition-dependent folding components FORS-M) can be routinely factored into analyses (3-5). <br /> .

      1.Simmonds P, Cuypers L, Irving WL, McLauchlan J, Cooke GS, Barnes E, STOP-HCV Consortium, Ansari MA. (2020) Impact of virus subtype and host IFNL4 genotype on large-scale RNA structure formation in the genome of hepatitis C virus. bioRxiv: https://doi.org/10.1101/202....<br /> .<br /> 2.Simmonds P (2020) Pervasive RNA secondary structure in the genomes of SARS-CoV-2 and other coronaviruses – an endeavour to understand its biological purpose. bioRxiv: https://doi.org/10.1101/202....<br /> .<br /> 3. Forsdyke DR (1995) A stem-loop "kissing" model for the initiation of recombination and the origin of introns. Mol Biol Evol 12, 949-958.<br /> .<br /> 4. Forsdyke DR (1995) Conservation of stem-loop potential in introns of snake venom phospholipase A2 genes: an application of FORS-D analysis. Mol Biol Evol 12, 1157-1165.<br /> .<br /> 5. Forsdyke DR (1995) Reciprocal relationship between stem-loop potential and substitution density in retroviral quasispecies under positive Darwinian selection. J Mol Evol 41, 1022-1037.<br /> 6.Forsdyke DR (2019) Hybrid sterility can only be primary when acting as a reproductive barrier for sympatric speciation. Biol J Linn Soc 128, 779-788.

    1. On 2014-11-18 17:25:26, user Patrick Deelen wrote:

      This is very interesting work. I really like your method to map reads, it is much more elegant than simply masking the genome. Also the integration of the different steps seems very convenient. I have a few questions I hope you are willing to elaborate on.

      1) How does you software deal with the cases where multiple SNPs / indels are present within a read. Considering the effectiveness of read based haplotype phasing this might happen quite often (http://www.ncbi.nlm.nih.gov... "http://www.ncbi.nlm.nih.gov/pubmed/24094745)")

      2) You mention the following in your manuscript: “Unknown polymorphisms in the sample are not considered but will typically have little effect since the tests of allelic imbalance are only performed at known heterozygous sites.” I’m wondering if this is also true for the analysis of rare variants. If there is a nearby un-typed variant it might be affecting the mapping of reads from one of the haplotypes. I realize that this is just as much a problem for the masking strategies but I’m wondering if you also performed simulations to show if this is problematic or not.

      3) For the validation data you state that you used 462 European GEUVADIS samples. However, 89 of the total 462 samples are Yoruba samples. Did you exclude these from the initial mapping? Please note that many of these GEUVADIS Yoruba samples are the same cell-lines as the 69 Yoruba LCL used by Pickrell et al.

    1. On 2018-08-05 11:49:39, user Tom Wallis wrote:

      I noticed that the equation on p.9, line 339 is wrong. This is the link function used for the ABX model presented in the supplementary material, not for the oddity model used for the main paper. I've uploaded a new manuscript to correct this error, which should be online shortly.

    1. On 2020-02-03 19:18:31, user Hannah Davis wrote:

      Out of curiosity, I just did a quick check of how many HIV-1 protein sequences there are in the NCBI database, because I suspected that the virus might be over-represented.

      Via the NCBI Taxonomy Browser, out of 6 012 978 total viral protein sequences, 1 169 134 are from HIV-1 alone.

      For comparison, there are only 57 759 protein sequences in the database from ALL Coronaviridae combined.

      This over-representation of HIV-1 in the database, combined with its famously high mutation rate, makes it VERY likely that any given short NT or AA sequence will show up in one or more HIV-1 sequence via blastp. Even if you ignore the effects of selection on viruses that may need to fold their proteins/interact with membranes/etc. in the same way.

    2. On 2020-02-02 02:08:23, user Connor wrote:

      I'm a logician so I'm fond of synopsis<br /> I'm not a geneticist

      Reading through the board though

      There was bat virus = A<br /> There's now ncov19 = B

      The difference between A and B rna is the insertion/addition of 4 sequences<br /> These 4 sequences are present in HIV<br /> They are also present in some related bat stuff and also not that uncommon generally

      There is also an artefact of the complexity of this stuff that a possible and previously seen (1919 flu) change in a very small common sequence can precipitate the rest<br /> We don't know the correlations there

      What I'd like an opinion on is

      How likely is it that <br /> The change from A to B happened in such a time frame commensurate with the emergence of B purely as an organic process

      Can I get a breakdown of probabilities (what u guys call 'E values'

      Thanks

    1. On 2021-05-12 01:01:15, user Yilin wrote:

      It was really interesting to read this paper because it is very relevant to what we learned in class. The contents of this paper was designed to flow in a perfect order. The paper was written in a language that was easy to understand for the audience. The figures were attached in between their sections rather than stacked all together in the end so that it was convenient to refer back and forward from the text and figures. As for the extravasation assay, it could be visible if a timeline and its fluorescence images were provided for the extravasation assay. As for figure 2g, it would be very helpful if the image or the font of the letters can be larger meaning the labels controls, “E-cad-, Tunable+DMSO, E-cad+, Tunable +Shield 1”. For figure 3e and figure 4k, it will serve as a better comparison if these two images can be arranged together to give the audience a more visual representation to show the shift of the color when blocking ERK phosphorylation.

    1. On 2023-07-04 11:41:03, user Zbyszek Boratynski wrote:

      It is very interesting paper. There was recent developments following McNab seminal work on relation among metabolism, body mass and home range size; on both inter- and intra-specific levels. These recent development in the experimental and comparative studies could help to resolve some ideas. Especially in the context of individual costs of mobility that seems to define daily activity and home range sizes.

      E.g.:

      Enriquez-Urzelai U, Boratynski Z. 2022. Energetic dissociation of individual and species ranges. Biol Lett 18:20210374. 10.1098/rsbl.2021.0374

      Boratynski Z. 2020. Energetic constraints on mammalian home range size. Func Ecol, 34: 468-474. doi: 10.1111/1365-2435.13480

    1. On 2024-07-31 13:32:54, user kbseah wrote:

      This looks very promising, congratulations! One point was unclear to me: which genome datasets were used to train the current mammalian model? The text refers to Table 1, but that just shows benchmarking results.

    1. On 2017-12-21 13:31:38, user Marcus wrote:

      Hi.

      Nice paper. Here are a few comments. I hope you don't mind the feedback...

      1. Canalization comes from the word canal, i.e, narrow transport channel. The patterns of auxin transport associated with phyllotaxis in the meristem epidermis are usually called "convergent". As far as I know, "canalization" hasn't been associated with such patterns previously. Rather, it is associated with vascular tissue formation and while PIN1 does form a channel below primordia, PIN1 is not required in these cells for phyllotaxis (Kierzkowski et al., 2013). So I find the terminology a little confusing and mixing up concepts. Could the authors simplify things by just talking about PIN1 expression levels and not bring "canalization" into it? The manipulations are only changing PIN1 levels, not activity I presume? Related to this, the authors could also easily talk about their phyllotaxis results in relation to plt mutants, which have a larger spacing between organs due to reduced PIN1 levels (Prasad et al., 2011).

      2. While the authors relate their phyllotaxis results to the Refahi stochastic model referenced, this model does not make any predictions in terms of how changing PIN1 levels might influence phyllotaxis. However Jonsson et al., (2006) does. This model specifically predicts that lower polar vs passive transport strength should lead to a larger spacing. This model was also recently supported by Bhatia et al., (2016).

    1. On 2021-02-10 07:24:23, user Irina Velsko wrote:

      Dear Authors,

      Thank you for this paper that addresses a mostly overlooked problem in metagenomics, it is an exciting push forward in the field. It is particularly relevant to the field I work in, ancient metagenomics, which deals with metagenomic data generated from historic and ancient sources. Ancient metagenome samples often have a very high proportion of reads that cannot be taxonomically classified, and determining the origins of these is of great interest. Because I hope to use your paper, based on modern data, to guide future ancient metagenome studies to address this topic, I was surprised to see you included 3 ancient metagenome studies in your analyses.

      Ancient samples are affected by a set of properties that require additional processing and validation steps that modern data do not. These include damage of the endogenous DNA, as well as contamination with modern organisms. Authentic ancient DNA (aDNA) damage is characterized by short fragment lengths typically less than 100bp, and conversion of cytosines to uracils, which then become thymines in the sequencing data. The presence of such damage patterns is used to authenticate ancient samples, and to distinguish endogenous DNA from exogenous, modern contamination.

      Ancient samples are obtained archaeological contexts, and are generally contaminated to at least some degree by environmental organisms derived from the burial environment. Particular steps need to be taken to remove these modern contaminants from taxonomic profiles or before assembly. Leaving them risks both assembling non-source organisms (such as assembling soil bacteria in oral samples), and of generating chimeric assemblies, which include reads from both ancient and modern sources. Indeed, the feasibility of assembling ancient metagenomes is still being assessed within the field, and the effects of aDNA properties on assembly is not well understood.

      For these reasons, I recommend replacing the 3 aDNA datasets (PRJEB6045, PRJEB12831, PRJEB15334) with 3 modern data sets. Unless the ancient datasets are fully authenticated, assessed for preservation (the level of environmental contamination), and the assemblies carefully checked to remove chimeras, there are many variables affecting the outcome of the assembly process that may interfere with drawing sound conclusions for your study.

      Finally, as the person who generated the data in PRJEB15334, I strongly caution the use of this version of the dataset. This data was auto-processed by the EBI-metagenomics pipeline, which does not account for any aDNA properties, and which systematically removes short DNA sequences (i.e., ancient DNA) during the quality control portion of its automated pipeline. Instead, if you would like to use this historic dataset, I recommend using PRJEB30331, which contains the full raw data of these same libraries but without the problematic auto-filtering step.

      For in-depth reading about the nuances of ancient DNA analysis, I recommend the following papers as a general introduction:

      A Robust Framework for Microbial Archaeology<br /> https://www.annualreviews.o...

      Mining Metagenomic Data Sets for Ancient DNA: Recommended Protocols for Authentication<br /> https://doi.org/10.1016/j.t...

      From the field to the laboratory: Controlling DNA contamination in human ancient DNA research in the high-throughput sequencing era<br /> https://www.tandfonline.com...

      Patterns of damage in genomic DNA sequences from a Neandertal<br /> https://www.pnas.org/conten...

      mapDamage2.0: fast approximate Bayesian estimates of ancient DNA damage parameters<br /> https://academic.oup.com/bi...

      Separating endogenous ancient DNA from modern day contamination in a Siberian Neandertal<br /> https://www.pnas.org/conten...

      Thank you, <br /> Irina Velsko<br /> velsko@shh.mpg.de

    1. On 2024-10-19 02:11:16, user Yak Nak wrote:

      The manuscript provides an exciting and valuable look into how circadian rhythms influence malaria transmission by aligning mosquito feeding behavior and parasite activity. The use of RNA-sequencing to uncover rhythmic gene expression in mosquito salivary glands is a significant strength and offers important new insights into the mechanisms behind malaria transmission. The figures are clear and effectively illustrate how these rhythms correlate with mosquito feeding efficiency and parasite infection capabilities, though the figure legends could benefit from more detailed explanations, especially for readers unfamiliar with gene expression data. The introduction is solid but could be improved by providing a more detailed discussion of previous research on circadian rhythms in malaria parasites to better frame the novelty of this study. The discussion section does a good job connecting the findings to broader vector-borne diseases like Zika and dengue, but it would be even stronger with specific examples of how these results could inform practical malaria control strategies, such as optimizing the timing of interventions based on mosquito feeding times. Overall, this is a well-conducted study with important findings, and a few revisions could further enhance its clarity and impact. Two follow-up questions:

      1. Could the authors clarify why specific time intervals (every 4 hours) were chosen for RNA-sequencing, and would more frequent sampling provide additional insights?
      2. Also, how might environmental factors such as temperature or humidity influence these circadian rhythms, and could this affect transmission in different regions?
    1. On 2018-03-30 12:51:33, user Daniel Ardeljan wrote:

      It might also be interesting to look at estimates of lab size on these papers and see if there are any associations with women belonging to smaller labs. If total number of authors on a paper is a good way to estimate lab size, it would provide a useful metric to analyze whether big labs tend to push towards higher impact journals, and whether women disproportionately run or join labs of different sizes.

    1. On 2021-12-09 06:47:40, user Robert George wrote:

      Great paper. One aspect which might be worth considering is the apparent settlement hiatus between Gravettian (~ 29 kbp) and Epigravettian (~ 26 kbp) in Italy (grosso modo) (see C14 curves https://www.sciencedirect.c... "https://www.sciencedirect.com/science/article/abs/pii/S1040618220306285)") . Striking also is the prevalence of Y-hg I2a2 in pre-Neolithic Italian pops, suggesting a founder effect

    1. On 2018-01-25 07:57:04, user Costa Vakalopoulos wrote:

      This study is intriguing and heralds a new direction for genomic studies on cholinergic pathways and their interactions with dopaminergic signaling. You’ll find a comprehensive theoretical framework for the pathways discovered here and especially cholinergic muscarinic dopaminergic signaling interactions through plcb ERK PI3k etc and their meaning for cognitive and affective dimensions at:<br /> https://www.frontiersin.org...

    1. On 2023-04-08 12:17:32, user Davidski wrote:

      Hello authors,

      Thanks for the interesting preprint and data. However, I'd like to see <br /> you address a couple of technical issues and perhaps one theoretical <br /> issue in the final manuscript:

      • the output you posted shows some unusual results, which are <br /> potentially false positives that appear to be concentrated among the <br /> shotgun and noUDG samples. I'm guessing that this is due to the same <br /> types of ancient DNA damage creating IBD-like patterns in these samples.<br /> If so, isn't there a risk that many or even most of the individuals in <br /> your analysis are affected by this problem to some degree, which might <br /> be skewing your estimates of genealogical relatedness between them?

      • many individuals from groups that have experienced founder effects, <br /> such as Ashkenazi Jews, appear to be close genetic cousins, even though <br /> they're not genealogical cousins. Basically, the reason for this is a <br /> reduction in haplotype diversity in such populations. Have you <br /> considered the possibility that at least some of the close relationships<br /> that you're seeing between individuals and populations might be <br /> exaggerated by founder effects?

      • thanks to ancient DNA we've learned that the Yamnaya phenomenon isn't <br /> just an archeological horizon but also a closely related and genetically<br /> very similar group of people. Indeed, in my mind, ancient DNA has <br /> helped to redefine the Yamnaya concept, with Y-chromosome haplogroup <br /> R1b-Z2103 now being one of the key traits of the Yamnaya identity. So <br /> considering that the Corded Ware people are not rich in R1b-Z2103, and <br /> even the earliest Corded Ware individuals are somewhat different from <br /> the Yamnaya people in terms of genome-wide genetic structure, it doesn't<br /> seem right to keep claiming that the Corded Ware population is derived <br /> from Yamnaya. Indeed, I can't see anything in your IBD data that would <br /> preclude the idea that the Corded Ware and Yamnaya peoples were <br /> different populations derived from the same as yet unsampled <br /> pre-Yamnaya/post-Sredny steppe group.

    1. On 2021-04-15 09:40:08, user Artur Czeszumski wrote:

      Hey,

      Great preprint. I enjoyed reading it. Here are some<br /> comments. They are mere suggestions :)

      Title and<br /> keywords:

      As there are not so many studies investigating joint<br /> actions with VR, maybe you should/could stress this in the title and<br /> keywords?

      There are papers on social interactions, but low-level<br /> joint actions are not so present.

      Introduction

      Your introduction is concise (maybe a bit too short) and provided all<br /> required information about the context of the study. However, the<br /> structure (order) is a bit strange for me. Starting with details<br /> about ERP components surprised me. I would suggest to flip the order<br /> and start with social interactions, then motor interactions, and at<br /> the end, action monitoring and its neural correlates. Furthermore, if<br /> you have an ERP discussion at the end of the introduction, you can<br /> follow it up with a static hypothesis or predicting results based on<br /> the previous research (this part is missing in the paper right<br /> now).

      Additionally, there are not so many studies using EEG and<br /> VR, and especially not so many studying joint actions (do you know<br /> any?), so you should highlight it in the introduction.

      Results

      In general, the results section is well structured and transparently<br /> presents results. However, I am missing the conclusion sentence after<br /> different results paragraphs. Apart from reporting ‘raw’ results,<br /> it helps the reader follow if you shortly conclude what this result<br /> means.

      Additionally, you report effect size in the analysis of<br /> asynchrony of button presses but not for Last pressed finger<br /> analysis. I suggest reporting them for all analyses in the<br /> paper.

      Discussion

      Similarly to the introduction, I would suggest adding a paragraph to highlight that<br /> you used EEG and VR to study joint actions.

      Methods

      I see one major shortcoming (problem) in your methods. Namely, you do<br /> not even mention that both EEG and VR glasses were on the head and<br /> how VR glasses could influence EEG signal. There are many labs<br /> worldwide testing this combination, and everyone has a multitude of<br /> artifacts, and people deal with them differently. This issue<br /> definitely cannot stay not discussed in your<br /> manuscript.

      Additionally, as far as I understand, you only<br /> removed eye artifacts with ICA and did not clean the data in any<br /> other way. Concerning that your paradigm involves VR, I find it<br /> strange. Additionally, every typical EEG dataset is never so clean<br /> that only eye artifacts contaminate data (I wish it would be<br /> different). There are many muscle artifacts. In case your<br /> participants made movements with hands/fingers, it is a crucial issue<br /> that should be addressed.

    1. On 2019-06-01 10:32:22, user Dr. Rajesh Kumar wrote:

      This is one of the cool paper where Reichert´s lab from HHU, Düsseldorf first time shows the that Mitochondrial cristae and crista junctions (CJs) both undergo frequent cycles of fusion and fission on a second-time scale. This is how the organelle itself undergoes frequent cycles of fusion and fission from the surface/outer membrane. <br /> The discovery of the dynamics/plasticity of the mitochondrial inner membrane (MIM) under physiological conditions was possible due to the STED super-resolution microscope. This is an important cellular process that may have a direct impact on the kinetics of chemical reactions, the structure of the OXPHOS system and cellular metabolism. I guess this is exciting to further zoom in the process that might open a new door where cristae dynamics may a promising therapeutic target to modulate metabolic dysfunction/mitochondrial disease.<br /> Congrats to the whole team !!

    1. On 2021-03-18 19:37:31, user Raidan wrote:

      Very interesting study. It has importance for how it might impact use of egg-grown reagents in testing & in interpreting PB clones from vaccinated people.<br /> Some of the questions: Were those IgG plasmablasts class switched B1 cells or what are they? & where do they class switch? <br /> -the nature of Ag or antigens inducing these Abs & location in vaccine? why are we sure it's only glycans since de-glycoslation doesn't reduce it a 100%<br /> -direct comparison to cell culture-based vaccines induced Abs in terms of level of HA-specific mAB (were there reeduced level in neutralization compared to these non-egg grown vaccines).

    1. On 2021-05-15 18:54:12, user David Ron wrote:

      The paper by Bhadra and colleagues claims that mycolactone binding to the Sec61 ER protein translocation channel favours leak of calcium ions from the ER to the cytosol via the drug bound channel. This is an interesting claim, as it stands to explain some of the pleiotropic consequences of exposure to this bacteriotoxin. An important experiment supporting this claim is presented in figure 4. There, having disabled the ER localised pump that replenishes the organelle with calcium (with the SERCA inhibitor thapsigargin), the authors measure the rate at which ER calcium concentrations decline as a function of time, comparing this metric of ER calcium leak between untreated and mycolactone treated cells. They go on to show that the accelerated decline in [Ca+2]ER brought about by exposure of the cells to mycolactone is abrogated by mutations in Sec61a known to affect mycolactone binding. It is unclear however, why they chose to measure the effect of mycolactone on this parameter after a lengthy exposure of 6 hours. The mycolactone derivative, cotransin blocks protein translocation with minutes (Garrison et al., 2005 PMID: 16015336), one might therefore expect, that if the basis of the accelerated calcium leak were a direct consequence of mycolactone binding to Sec61, it too might be realised within minutes of exposure to the drug. This may affect the interpretation of this crucial experiment, as altered calcium leak, 6 hours into exposure of a drug that blocks the translocation of some protein into the ER, may be an indirect consequence of processes other than that claimed by the authors.<br /> David Ron<br /> University of Cambridge

    1. On 2020-06-18 20:28:33, user Lee Kerkhof wrote:

      Alfonso Benitez-Paez and Yolanda Sanz were the first to test rRNA operon sequencing on the ZymoBiomics Mock Community with MinION (doi: 10.1093/gigascience/gix043) while Kerkhof et al. demonstrated consensus building for error correction using rRNA operon profiling from soil/bioreactor DNA with the MinION (doi: 10.1186/s40168-017-0336-9). It is unclear why this prior work is not cited in your submission.

    1. On 2020-09-09 16:34:27, user Stanislav Vitha wrote:

      Very interesting paper; I am eager to try FLIMJ for data exported from our Leica SP8 FALCON and hope I will be able to recommend this to the users of our core facility.<br /> I noticed one issue with the pre-print (html version) - Figure 4 is not shown, instead Fig. 3 is displayed the second time where Fig 4 should be. The PDF version is correct.

    1. On 2015-11-18 04:51:22, user deanna.church@gmail.com wrote:

      Looking at Supplemental tables 8 and 9- I was expecting to find the actual variants in these tables, but these don't seem to have variant information, just gene information. Can the variant information be added?

    1. On 2020-05-03 20:52:07, user Jean-Yves BOULAY wrote:

      This paper may interest the author: this article investigates the molecular modules system proposed by Professor Sergei Petoukhov. This study describes numerous phenomena of symmetry in the distribution of the amino acids in the genetic code table. These phenomena consist to arithmetical arrangements of sets of modules numbers, or/and protons numbers which are counted in each of the 20 amino acids used by the standard genetic code. These arithmetical phenomena are by configurations of multiples of prime numbers also.<br /> https://www.researchgate.ne...<br /> some examples :<br /> Without the rebel group (see paper):<br /> In the genetic code table, the total modules sum of the columns 1and 2 (126 + 112) and the total modules sum of<br /> the lines 3 and 4 (122 + 116) are identical! And the sum of the right chequered configuration is also the same.<br /> Also, the total modules sum of the columns 3 and 4 (114 + 158) and the total modules sum of the lines 1 and 2<br /> (144 + 128) are identical! And the total modules sum of the second chequered configurations is also the same.<br /> https://uploads.disquscdn.c...

    1. On 2021-04-29 15:48:47, user Anne Murphy wrote:

      Very interesting paper. As shown in Figures 1D and 3A, microglia are still present following the various ablation techniques. How do you know the levels present were not sufficient enough to drive OIH? <br /> Also - neither mice nor rats have a 'gender'; rather, they have a biological sex.

    1. On 2020-07-09 17:46:47, user anonymous wrote:

      where is the data that shows these reactive cells are protective and for how long? The assumption that this confers long-term immunity is pure speculation. T cell immunity rather than B cell predominant immunity implies reinfection is guaranteed; t cells only respond to infected cells.

    1. On 2018-11-28 18:11:32, user mialsmith wrote:

      In this paper, Ueyama et al. proposed Rac-dependent paracrine signal from keratinocytes to intradermal pre-adipocytes that promotes adipogenesis. Using K5-Cre;Rac1flox/flox;Rac3-/- (Rac1/Rac3-DKO) mice, the authors showed that Rac3-/- exacerbated hairless phenotype observed in K5-Cre;Rac1flox/flox (Rac1-KO) mice (Fig. 1D), reduced skin thickness and fat content in the dermis (Fig. 3A and B). Ueyama et al. then showed that BMP2 and FGF21, potentially produced by keratinocytes in a Rac-dependent manner (Fig. 4A and B), can induce differentiation of adipocyte precursors in culture (Fig. 6B). Although the authors provided good evidence that BMP2 and FGF21 promotes differentiation of adipocyte precursors, there is not enough data supporting the claim that these signaling ligands were produced in keratinocytes in a Rac-dependent manner in vivo. My major concerns with this paper involve the expression of Rac3 in keratinocytes and potentially adipocyte precursor, the quantification method for gene expression, and the in vivo aspect of this proposed mechanism.

      My first concern involves the expression of Rac3 in skin. Fig. 1 A and B showed the expression of Rac3 in keratinocytes at mRNA level, albeit not high. I think it is essential to show that Rac3 is expressed at protein level as well especially when their mRNA level is low. Although Ueyama et al. wanted to study the Rac-dependent signaling from keratinocytes to adipocytes, the Rac3-/- mouse model is not an epidermis specific knock out. Therefore, if Rac3 is expressed in adipocytes and plays a role in its differentiation, then there might be a confounding factor in this study. Expression of Rac3 has been shown in 3T3-L1 cells and adipocytes from ependymal tissue (Lira et al., 2018), hence there is a possibility that Rac3 is expressed in skin adipocytes and plays a direct role there. To eliminate this possibility, Rac3 expression in adipocytes in wild type and Rac3-/- mice should be compared at mRNA level (using qRT-PCR) and protein level (using western blot).

      Secondly, Ueyama et al. only used RT-PCR to quantify expression of Rac genes and to validate ligand expression from DNA microarray data. However, this method was difficult to draw quantitative conclusion about differential gene expression. In Fig. 4B, the authors included Beta-Actin as loading control, but interestingly, Beta-Actin amplification did not increase with more cycles suggesting saturation already occurred in fewer than 25 cycles. Therefore, beta-actin RT-PCR was not a great control in this case as saturation might be reached at different cycles in DKO and Rac3-KO. I would suggest using qRT-PCR to quantify gene expression at mRNA level because it is a more standard method and provides quantitative data. In addition to quantifying gene expression at mRNA level, it would further support the paper’s argument if gene expression at protein level was also established as mRNA expression does not always correlate to protein production. For experiment in Fig. 4B, I would be more confident to conclude that those 5 factors were synthesized if a western blot of total protein lysate of keratinocytes were extracted and probed for at least BMP2 and FGF21 (available antibodies), or maybe even consider performing immunofluorescence (IF) of whole skin to look at these potential ligands in situ.

      Expression of potential signaling ligands brings me to my last major concern involving the in vivo aspect of this proposed signaling mechanism. The paper showed combination of at least 2 factors could induce 3T3-L1 fibroblasts to produce lipids in vitro (Fig. 4C and D), yet this approach was not sufficient to show that these ligands would indeed induce adipogenesis in vivo. Although Ueyama et al. showed 72-hour mouse primary keratinocytes culture media can induced differentiation of 3T3-L1, the effect is extremely mild compared to addition of BMP2 and FGF21/FGF20 (Fig. 5A). In addition, for experiments in 5B and C, it was interesting that human derived NHEK culture media were used to stimulate mouse derived 3T3-L1 differentiation which is likely not what happen in a normal mouse or human tissue. I think the authors can bolster their argument if they show that compared to DKO mice, Rac3-/-, Rac1flox/flox, and K5-Cre;Rac1flox/flox mice have higher amount of candidate signaling ligands and more differentiation of intradermal white adipocytes (using in situ IF or at least western blot of keratinocyte proteins).

    1. On 2024-06-05 18:16:30, user Coleen Murphy wrote:

      Point-by-point critique of Gainey et al. 2024:

      Figure 1: <br /> 1. (A-C) It has been reported by many groups that PA14 is mildly attractive to C. elegans, that is, given a choice between PA14 and OP50, worms choose PA141,2. However, in almost every assay shown in this paper, the worms prefer OP50 over PA14 – that is, they are already avoiding PA14 - prior to training (naïve preference), which is odd. This suggests that the authors are not using conditions that are standard, either in PA14 or OP50 growth or in choice assays (see note about choice assay performance). This is a serious cause for concern that is independent of any training conditions. In fact, as far as we can see, in only one case (Fig. 1C, F1) did their experiments replicate the naïve choice results observed by other groups. <br /> 2. Choice assays: their “choice assays” involve putting 3-4x the recommended number of worms on a plate (up to 770 on a spot!), letting them roam for variable amounts of time (“30-60 minutes”) without trapping them (no azide or other paralytic used), and then putting them in a 4°C incubator (which does not immediately halt worm movement), then counting them. None of this follows our published choice assay protocols, or the standard chemotaxis assay protocol3–6. Putting more than 200 worms on a single plate can lead to altered choice because of crowding. In the absence of a paralytic, worms change their preference due to various factors, including adaptation; therefore, in this case, the worms’ first choice (which is what we measure in all our assays) is not being measured. They also count the worms by “aspirating” the worms off of the plate, which is not standard in any behavioral assays, as far as we know.<br /> 3. Table 2 and Figure 1: There are almost no true replicates, as in each experiment, at least one or more condition is changed. (For example, the authors only tested the PA14 we sent them in one replicate - Exp 3). <br /> 4. daf-7p::GFP imaging experiments (Fig. 1D, F, H) – Hunter and colleagues do not report seeing increased daf-7p::gfp expression in the P0 generation. Increased daf-7p::gfp expression after exposure to PA14 has been reported by multiple groups7, not just ours, and is usually not small or highly variable, as it is due to the combination of bacterial cues and P11 small RNA; if they cannot replicate this basic result, it suggests that something is seriously wrong with their protocols or technique, or their worms are very sick, even before trying to use our protocol to train worms. <br /> 5. Additionally, they do not report the expression of daf-7p::gfp in the ASJ neuron7, which is very strange, since we have been able to reliably replicate Meisel, et al.’s finding in the P0 generation. Therefore, it is not clear from which neuron the authors are quantifying daf-7p::gfp levels. <br /> 6. Instead of imaging and reporting fluorescence levels in individual neurons, the authors averaged fluorescence intensity/worm, which is explicitly not what we did or others have done, because different neurons in each worm can have different intensities – particularly if they are the ASI rather than ASJ neurons. <br /> 7. While we see modest decreases in fertility after PA14 training, the authors report severe decreases in fertility: about one fifth of normal egg production, and a severe developmental delay) in their F1 generation that we do not observe. Both facts indicate that their worms are very sick, even the worms that have not been exposed to PA14. If their worms are extremely sick, it might account for the small number of progeny, poor imaging results, and a developmental delay that shifted the training times. This could be a result of overbleaching, which causes developmental delays; the bleaching protocol described in Gainey et al. deviates from our published protocol. Additionally, they add Triton X100 to their final M9 wash, which is used (although at a higher concentration) to permeabilize embryos in other protocols. We are not aware of any bleaching protocols that include Triton in a wash step, and our lab certainly does not; this addition might also damage the progeny.

      Figure 2 <br /> 1. P0 imaging data suggest that the daf-7p::gfp response to PA14 is not reproducible in their hands; again, this has nothing to do with our paper or protocols, but rather appears that they cannot replicate previous results in the field that precedes our work. <br /> 2. Does “25°C” mean that the worms were grown at or assayed at 25°C, or both? This high temperature is generally hard on the worms. <br /> 3. Technical note: it appears that instead of consistently picking fluorescent daf-7p::gfp animals, the authors “chunked” large groups of worms, resulting in populations of non-fluorescent animals in their experiments. <br /> 4. Scale of P0 and F1 are extremely different (due to sickness of the P0s?).

      Figure 3 <br /> 1. Notes that panels A, C, and D are repeated from Figure 1.<br /> 2. The authors discuss “OP50 aversion” but this does not make sense, since both trained and untrained animals are placed on HGs after bleaching. <br /> 3. Their naïve in F1 is sometimes even lower than in the P0 (Fig. 3D).<br /> 4. There is no consistency in their results across replicates, within experiments, or across figures of the paper – not just the inability to see an F2 effect, but in their naïve chemotaxes, P0 trained choice indices, and F1 results; the authors claim that their F1 assays are reproducible, but only 3 out of the 9 assays in this figure show F1 learned avoidance. <br /> 5. In 3J, data that are not replicates, as they have been performed using different conditions, have been pooled. <br /> 6. Gainey et al. observe substantial variation in behavior between training plates (Figure 3, table 2, S2 annotated protocol), and incorrectly treat each training plate as a biological replicate, rather than a technical replicate. (Each training plate is seeded and grown in the same conditions, and worms from the same bleached population are added onto the plates, therefore these are not biological replicates but rather technical replicates; biological replicates require starting with different worm populations and carrying out the whole experiment independently.) In our hands, behavior from a set of training plates is always consistent. <br /> 7. Additionally, we note that the authors use the same population of worms for the choice assays and subsequently for bleaching, meaning that worms are held in liquid for an extended time before bleaching; this may cause worms additional stress which may interfere with behavior.

      Figure 4 <br /> 1. OP50 growth conditions: this would only matter if the controls and experimentals were grown on different plate types, which is not the case (but if the authors are in fact putting the controls on different plates from experimentals, then the experiment is done incorrectly).

      Figure 5 <br /> 1. We also found that sid-1 and sid-2 are required, but since their controls are inconsistent (Fig. 3) in the first place, it is hard to know how to interpret their data. <br /> 2. Other mutants (rde-1, hrde-1, sid-1, sid-2) – still show increased daf-7p::gfp in F1 – again, these data are hard to interpret since they do not show a wild-type control that worked here. This also has little bearing on our work since other training paradigms (e.g., 4- and 8-hour training that engages small RNA-independent pathways) also induce daf-7p::gfp. It is also unclear which neuron (ASI vs ASJ) they are imaging.

      Discussion <br /> 1. daf-7p::gfp - Picking fluorescent worms or rollers is standard worm husbandry; it is not a “result” to say that they noticed that Rol can be lost – but it does indicate that they should have discarded any results that they obtained before noticing that the array might have been lost in the worms they assayed. The fact that they have brought this up more than once suggests that they are not using standard accepted practices to maintain transgenic lines. <br /> 2. Dennis Kim’s work on phenazine-induced avoidance has been oddly neglected in this work7. Kim’s group found that phenazine-1-carboxamide induces Pdaf-7::gfp expression in the ASJ neuron, which we see quite reliably in our assays as well. No Pdaf-7::gfp imaging of the ASJ neuron is presented in this work, suggesting that either the PA14 they grew also did not make phenazines, or their image analysis is unreliable. <br /> 3. They made a lot of changes to our protocol (temperatures, light/dark, etc). We cannot find in this paper a single example of an experiment that followed our protocol entirely. <br /> 4. The authors make a point of calling OP50 a pathogen, which is odd; C. elegans grown on OP50 typically live for 2-3 weeks. They cite Garigan et al. 20028, which showed that when worms get old (past 15 days) eventually the pharynx stops grinding up bacteria and the gut will start to fill up with OP50, and killing bacteria does slightly extend lifespan - but this is not an effect observed in young (Day 1) animals on the short timescales used in the experiments here. In any case, since both control and trained animals are grown on HG plates with OP50, it cannot explain the behavior of the control animals. <br /> 5. The authors also never replicate the “bias towards Pseudomonas in choice assays ((Ha et al., 2010; Lee et al., 2017; Moore et al., 2019)” – Those papers also used OP50 vs PA14 to demonstrate this bias towards Pseudomonas, so it is unclear how the author think that their failure to replicate this basic finding is somehow supportive of any of their arguments. It is more likely that there is something fundamentally wrong in their initial conditions that have prevented the replication of all other groups’ findings, not just ours. Moreover, in our experiments, other than the 24 hrs of training on PA14 vs OP50, our control and trained animals are always on the same plates. This argument makes no sense, unless the authors have introduced an additional variable of plating control worms on one kind of plate/bacteria and their trained animals on a different plate/bacteria (which we do not do). <br /> 6. It is unclear why the authors grew worms at different temperatures. 20°C is the standard temperature for worm growth and assays. <br /> 7. In our hands, naïve OP50-PA14 choice index is not significantly different between P0 (when NGM plates are used) and the subsequent generations (when HG plates are used). The survival assay correlates well with the idea that their worms are very sick, much sicker than we see in our assays, although the sparse intervals in both assays make it difficult to draw any conclusions – not possible to draw the conclusion that the bacteria are “more lethal” since they are trying to compare two lifespans from different labs etc. - but if they are, it might be due to their PA14 cultivation conditions or the health of their worms. But the fact that they see massive leaving and desiccation of worms, they might indeed be growing PA14 under much more pathogenic conditions. <br /> 8. The authors state: “Near the conclusion of these experiments, we received an updated protocol that included several clarifying edits and additional deviations from the published protocols (C. Murphy, Personal communication).”

      We clarified our protocols, we didn’t “deviate” from them. This is a concerning way to present our email communications in which we tried to correct errors in their protocol and offer constructive advice; we even extended an invitation to Hunter to visit our lab to learn the assay. We are happy to provide these emails if necessary.

      In order to help others, we continuously update our lab’s protocols to make clarifications that will help future users. Any note from the Murphy lab is an example of this type of updating. For example, later we made a new bacterial construct that used a Kan marker and constitutive promoter instead of an Ara inducible promoter and Carb marker to streamline experiments. This is not a deviation, it is a natural progression of the research in our lab and our practice of continuously improving our assays and updating protocols.

      It is disingenuous for the authors to present our updates to our protocols as if we have “deviated” from them – in every instance, we gave the authors all of the information that we had available to us at the time. Our suggestions were made genuinely and in good faith, with the assumption that the authors wanted to get the assay working rather than using it to point out changes in our protocol.

      Moreover, this statement corroborates our assertion that all or most of the data in this paper seem to have been generated using a protocol that differs significantly from our lab’s, as the bulk of their experiments appear to have been done before contacting us: “Incorporating these changes into our procedures did not reliably alter our results.” (no data shown)

      1. “[T]his example of TEI is insufficiently robust for experimental investigation of the mechanisms of multigenerational inheritance” – The authors failed to test the fundamental requirement for transgenerational inheritance, that is, the expression of P11 sRNA by PA14, which only happens on plates at 25°C. Since they cite our subsequent papers where we first identified P11 sRNA as the key to TEI9, then our finding that the Cer1 retrotransposon is also required for P11-mediated TEI10 and then our finding that other Pseudomonas species use a similar small RNA to induce TEI11, they are definitely aware of this fact. Thus, it is not clear to us why they have not attempted to test P11 sRNA levels while searching for conditions that would replicate our findings. As a result, we can never know whether P11 sRNA was produced in any of the conditions that the authors tested in the experiments shown.

      Together, Hunter and colleagues’ failure to replicate the basic naïve attraction to PA14 over OP50 demonstrated by other labs, their failure to replicate the P0 daf-7 expression published by other labs, and their failure to reliably replicate the P0 and F1 behaviors shown by other labs suggests to us that there are more basic concerns about their bacterial and C. elegans growth conditions, assay conditions, and assay techniques independent of any of the attempts to replicate the findings from our work.

      References <br /> 1. Zhang, Y., Lu, H., and Bargmann, C.I. (2005). Pathogenic bacteria induce aversive olfactory learning in Caenorhabditis elegans. Nature 438, 179–184. https://doi.org/10.1038/nat....<br /> 2. Ha, H., Hendricks, M., Shen, Y., Gabel, C.V., Fang-Yen, C., Qin, Y., Colón-Ramos, D., Shen, K., Samuel, A.D.T., and Zhang, Y. (2010). Functional Organization of a Neural Network for Aversive Olfactory Learning in Caenorhabditis elegans. Neuron 68, 1173–1186. https://doi.org/10.1016/j.n....<br /> 3. Moore, R.S., Kaletsky, R., and Murphy, C.T. (2019). Piwi/PRG-1 Argonaute and TGF-? Mediate Transgenerational Learned Pathogenic Avoidance. Cell 177, 1827-1841.e12. https://doi.org/10.1016/j.c....<br /> 4. Moore, R.S., Kaletsky, R., and Murphy, C.T. (2021). Protocol for transgenerational learned pathogen avoidance behavior assays in Caenorhabditis elegans. STAR Protoc. 2, 100384. https://doi.org/10.1016/j.x....<br /> 5. Kauffman, A.L., Ashraf, J.M., Corces-Zimmerman, M.R., Landis, J.N., and Murphy, C.T. (2010). Insulin Signaling and Dietary Restriction Differentially Influence the Decline of Learning and Memory with Age. PLoS Biol. 8, e1000372. https://doi.org/10.1371/jou....<br /> 6. Kauffman, A., Parsons, L., Stein, G., Wills, A., Kaletsky, R., and Murphy, C. (2011). C. elegans Positive Butanone Learning, Short-term, and Long-term Associative Memory Assays. J. Vis. Exp., 2490. https://doi.org/10.3791/2490.<br /> 7. Meisel, J.D., Panda, O., Mahanti, P., Schroeder, F.C., and Kim, D.H. (2014). Chemosensation of Bacterial Secondary Metabolites Modulates Neuroendocrine Signaling and Behavior of C. elegans. Cell 159, 267–280. https://doi.org/10.1016/j.c....<br /> 8. Garigan, D., Hsu, A.-L., Fraser, A.G., Kamath, R.S., Ahringer, J., and Kenyon, C. (2002). Genetic analysis of tissue aging in Caenorhabditis elegans: a role for heat-shock factor and bacterial proliferation. Genetics 161, 1101–1112. https://doi.org/10.1093/gen....<br /> 9. Kaletsky, R., Moore, R.S., Vrla, G.D., Parsons, L.R., Gitai, Z., and Murphy, C.T. (2020). C. elegans interprets bacterial non-coding RNAs to learn pathogenic avoidance. Nature 586, 445–451. https://doi.org/10.1038/s41....<br /> 10. Moore, R.S., Kaletsky, R., Lesnik, C., Cota, V., Blackman, E., Parsons, L.R., Gitai, Z., and Murphy, C.T. (2021). The role of the Cer1 transposon in horizontal transfer of transgenerational memory. Cell 184, 4697-4712.e18. https://doi.org/10.1016/j.c....<br /> 11. Sengupta, T., St. Ange, J., Kaletsky, R., Moore, R.S., Seto, R.J., Marogi, J., Myhrvold, C., Gitai, Z., and Murphy, C.T. (2024). A natural bacterial pathogen of C. elegans uses a small RNA to induce transgenerational inheritance of learned avoidance. PLOS Genet. 20, e1011178. https://doi.org/10.1371/jou....

    1. On 2023-01-09 15:10:22, user Daniel Wong wrote:

      Hi Greg!<br /> Thanks for reviewing the preprint — it will definitely help to make the manuscript better and improve the science. For the minor comments, I will go through them individually and make changes as necessary to the paper before its official publication. For the major comments:<br /> - The repo will be made public soon depending on how quickly Pfizer’s IP department can review and approve it — apologies for the delays.<br /> - For the CP embeddings, we actually derived from two sources as described in Methods:<br /> - JUMP Pilot: We downloaded from the repo https://github.com/jump-cel.... To our understanding, this repo was created by the same people who made the JUMP Pilot dataset, and they provided the source and instructions for downloading the CP embeddings used in their study here: https://www.biorxiv.org/con.... If you have another source for embeddings, I’m happy to analyze them!<br /> - LINCS: We downloaded them from the repo: https://github.com/broadins.... To our understanding, this repo was created by one of the main developers and maintainers of DeepProfiler for use in benchmarking DeepProfiler against CellProfiler, so we thought that it was satisfactory but we could be mistaken! As with the JUMP Pilot, if there is a better source for embeddings, I’m also happy to analyze them if you can provide a CSV. <br /> - We purposefully chose level 3 (un-normalized) embeddings because the MP profiles are also un-normalized and we wanted to compare like to like. MP's embeddings are pulled directly from the model's hidden state without any post-processing or plate / DMSO normalization. Hence if there are better embedding sources, it would be helpful if you could provide level 3 ones. <br /> - We did not try combining datasets — that’s part of a potential future work which I anticipate would boost performance as we expose the model to more diversity. Although interesting, we saw this as out of scope for supporting the main claims of the paper. For this paper at least, we did not do a cross analysis (i.e. Model trained on A but evaluated on Dataset B). It might be an interesting supplemental analysis, but we thought that prediction on held-out compounds was sufficient to prove the point we were trying to make. Strong model generalizability to other datasets instead of generalizability to new compounds (as in the current study) will be left as a future (and very exciting!) exercise. <br /> Thanks for taking the time to review and help improve the work. I admire what your group is doing for advancing open science!<br /> With gratitude,<br /> Daniel

    1. On 2017-03-13 19:35:39, user Evan Eichler wrote:

      We thank Barrett et al. for reporting these issues. We just received this formally from Nature Genetics this morning (3/13) and are working to address the comments and make necessary changes as part of a correspondence through the journal.

    1. On 2021-11-18 00:31:40, user Iris Young wrote:

      This manuscript describes the first use of microED diffraction data for ab initio phasing and the instrumental setup necessary to achieve it. While the authors have presented phasing as the major accomplishment here, we find the modifications to the data collection process much more interesting. Firstly, any diffraction dataset at this resolution should be amenable to ab initio phasing, if the intensities are measured accurately enough. Secondly, the conditions under which such accurate intensity measurements can be made and how accurate they need to be to enable phasing are not adequately explored here; this is a proof-of-concept but not yet fleshed out in a way that lets us know how useful it will be. The description of how this was enabled, by contrast, is very well-detailed and immediately valuable to the scientific community. We will address both foci of the paper but will recommend the authors either shift the narrative to better center this work's strengths or carry out additional computational experiments.

      First, regarding phasing/the accuracy of the intensities: Building on this group's tremendous effort to advance the capability of microED to produce high-resolution crystal structures from nanocrystals on TEM grids from only minutes of data collection, the authors now present proof of concept for ab initio phasing of small proteins from such datasets. Whereas molecular replacement has all but obsoleted ab initio phasing of proteins with known structures or homologs, truly new structures remain nontrivial to determine by crystallography, where unmeasured phases limit us. Still, the short data collection times for microED, relative ease of preparation of nanocrystalline samples, and increasing accessibility of electron microscopes could make ab initio phasing a powerful option. The capability for ab initio phasing of macromolecules is therefore, in this context, another core strength of the method.

      The prospect of using direct methods for phasing structures missing easily discernible secondary structures is a natural next step. The authors probe the limits of the datasets in the current manuscript, describing multiple attempts at phasing and detailing which did and did not come to fruition, and suggest further routes for optimization. There is further analysis possible here that we would very much like to see:<br /> - Why are the resulting R-factors so poor compared with X-ray crystallographic structures of comparable resolution? If the authors apply the same phasing methods to X-ray and microED datasets of the same molecule side-by-side, what differences emerge? What fundamental differences can we expect between datasets from these two methods, including major sources of error, and how should we plan to account for them? The availability of HEWL structure factors from XRD (http://scripts.iucr.org/cgi-bin/paper?S0907444997013656), with very low R-factors, could also enable an analysis of the errors in the intensities derived from microED, with very high R-factors, which we would be very keen to read.<br /> - Thinking now of applicability beyond model systems, at what resolution/accuracy of intensity measurements (both of which might be limiting in other cases for microED) should we expect ab initio phasing to be possible? While the space of potential fragment inputs is explored, the only exploration of the structure factor inputs are the lysozyme or proteinase K datasets. Truncations and noise additions to these datasets can provide a guide of the applicability of the method and the importance of the new, more accurate, data collection setup.

      We find the very thorough description of all stages of instrument setup, sample preparation and data processing to be indispensable. The authors describe in detail what steps were taken to ensure the experiment was physically possible and why they were necessary. Most importantly, using the microscope in diffraction mode is normally incompatible with the dynamic range of the detector, so the authors describe overriding an engineering control that disables the camera in diffraction mode and selecting a variety of instrument settings (spot size, C2 aperture, beam size, microprobe mode, and exposure time) to keep the dose per frame as low as possible. Their successful ab initio structure solution of proteinase K and lysozyme using this setup and standard crystallography data processing software is a convincing proof of concept of this setup. Framed a little differently, this work could certainly stand on its own as a description of the instrumental setup necessary to produce these datasets.

      In summary, the manuscript is generally well-written, detailed and clear. It is accessible to the average cryoEM microscopist as well as sufficiently complete from the perspective of a methods developer. Aside from our concerns with the framing of the limits of applicability to different resolutions and intensity accuracies, we find no major issues with the work that should delay its wider adoption.

      One minor comment:

      • “For MicroED data from three-dimensional macromolecular crystals, phases have thus far only been determined by molecular replacement.” We note that this group has used radiation damage for phasing too: https://pubmed.ncbi.nlm.nih.gov/32023481/

      Iris Young and James Fraser (UCSF)

    1. On 2020-05-06 06:27:32, user David Posada wrote:

      Dear Daniele et al,

      I am a bit confused, how is it possible to use methods for *clonal* deconvolution –which assume no recombination and infinite-site models– in a virus that recombines and with multiple mutations at individual sites?

    1. On 2023-02-09 15:07:21, user Leyla Slamti wrote:

      The topic of this manuscript is of<br /> great interest for the Bacillus cereus community. The authors present a lot of<br /> data and the results about temperature-dependent PapR maturation reveal new information<br /> about the mechanisms underlying quorum-sensing in these bacteria. However, in my<br /> opinion, the conclusions regarding expression heterogeneity are based on data<br /> that present a major flaw. Plasmid pHT315 is not appropriate for the measurement<br /> of fluorescence intensity because it induces heterogeneity in itself, probably<br /> because of its copy number. The authors should have verified this by using a<br /> control such as the promoter of a constitutively-expressed gene. They would<br /> have seen the same kind of result as they see with PlcR-regulated genes. Plasmid<br /> pHT304 should have been used instead. The reference for plasmid pHT315 is wrong.<br /> It should be Arantes and Lereclus Gene. 108 (1991)115-l 19. The difference in<br /> cell morphology between strains that only differed by the reporter fusion they<br /> carry is also puzzling (chains or filaments, it's difficult to say, versus individualized<br /> cells ; Figure 2). Are the bacteria sick? Could this influence the expression<br /> results? It would have been helpful to show the growth curves corresponding to<br /> each strain at each temperature to determine if bacterial growth was affected<br /> by the reporters used.

    1. On 2022-05-05 17:37:41, user Ke Hu wrote:

      The number of microtubules in the cortical array of Toxoplasma gondii is nearly invariant

      John Murray and Ke Hu

      Biodesign Center for Mechanisms of Evolution/School of Life Sciences, Arizona State University, USA

      This cryo-electron tomography analysis of the apical cytoskeleton of Toxoplasma gondii [1] from Sun, Segev-Zarko, Chen et al. provided exciting new structural details for the parasite apical complex and associated structures. However, as we discussed with the authors prior to the publication of the paper, we found the high percentage (>50%) of parasites that did not have 22 cortical/subpellicular microtubules in the reported dataset surprising and was not consistent with what our lab has observed in the course of over a decade of working on Toxoplasma cytoskeleton. To make sure we were not just going by a preconceived bias, we imaged non-extracted parasites in which the cortical microtubules were fluorescently labeled by TrxL1 endogenously tagged with mEmeraldFP [2]. We collected ~150 three-dimension (3D) structured illumination microscopy (SIM) image stacks, choosing fields that appeared to include at least one parasite viewed end-on. In total, those 3D stacks contain images of ~ 1500 parasites. From those 1500, we selected 106 parasites that were oriented such that it was possible to count unambiguously all of the cortical microtubules in a single slice of the 3D-SIM stack. Of these 106 parasites, 104 have exactly 22 microtubules and 2 have 24 microtubules. Our conclusion is that the overwhelming majority of parasites have 22 microtubules, and that the frequency of deviation from this predominant configuration is of the order of 2%. The significance of this low level of variation will be fully appreciated only when it becomes possible to propose detailed cellular mechanism for the patterning of the cortical array of microtubules.

      References:

      1. Sun, S.Y., L.-a. Segev-Zarko, M. Chen, G.D. Pintilie, M.F. Schmid, S.J. Ludtke, J.C. Boothroyd, and W. Chiu, Cryo-ET of Toxoplasma parasites gives subnanometer insight into tubulin-based structures. Proceedings of the National Academy of Sciences, 2022. 119(6): p. e2111661119.

      2. Liu, J., L. Wetzel, Y. Zhang, E. Nagayasu, S. Ems-McClung, L. Florens, and K. Hu, Novel Thioredoxin-Like Proteins Are Components of a Protein Complex Coating the Cortical Microtubules of Toxoplasma gondii. Eukaryotic cell, 2013. 12(12): p. 1588-99.

    1. On 2017-08-08 09:09:42, user Martin Modrák wrote:

      So I've been testing the idea of using BUDS as a preprocessing step for further analysis of scRNA-seq data. Using the R package was straightforward, good work! While trying to understand the results, I noticed that there should AFAIK be a strong symmetry in the posterior distribution of tau - whenever tau[i] = s[i] for all i, then setting tau[i] = 1 - s[i] and swapping the shape parameters of the beta distribution should give exactly the same posterior probability. In other words, inverting the trajectory in time should give the same results. This would in turn mean that the posterior is bimodal / non-identifiable and should break the solver. However, this is not what happens: multiple runs of variational Bayes (ADVI) converge on almost exactly the same paremeters, and full NUTS (only one run tried as it was pretty long) gives very similar results to ADVI and no divergences.

      Did you somehow explicitly break this symmetry in your model? From my reading of the code I could not find a place where this happens.

      I have also not managed to get meaningful results with BUDS on the dataset I am working with, but it is well possible (maybe even likely) that the data actually does not have a clear time continuity as expected by BUDS. I could send you the dataset if you happen to be interested (it is the ILC3 cells identified in https://www.nature.com/ni/j... - GSE70580).

      I also want to reiterate that it's great you've shared your work as a preprint and code on GitHub, otherwise I won't be able to make any of those tests. <br /> Are you comfortable with discussing the paper here or would you prefer other channel? (e-mail / GitHub issue / ....)

    1. On 2019-11-14 17:34:47, user Lynsey Hall wrote:

      Between pre-print and final publication, the gene set analysis was re-run using a mixed linear model framework to account for LD induced correlations between gene expression and to covary for gene length and number of SNPs in the gene. This changed the results from the 5 gene sets listed in the pre-print to 2 gene-sets: abnormal<br /> CNS synaptic transmission and antigen processing and presentation of<br /> peptide antigen via MHC class I (GO:0002474). We also compared the data more thoroughly to the existing literature (which evolved substantially between our initial submission to a journal in August 2018, and our submission to HMG in June 2019). Lastly, we offered a more thorough and empirical analysis of why the TWAS based gene set results differ from the GWAS based gene set results of the same data.

    1. On 2021-04-26 21:18:39, user Pavel Flegontov wrote:

      I read your paper with interest. It documents a known but indeed underappreciated issue: D- or f4-statistics should be interpreted in the phylogenetic sense, i.e. for a statistic (O, A; B, C) a positive value means a gene flow in any direction either between O and B or between A and C (I use the sign convention common in human archaeogenetics). Moreover, the sources of the flow can share just a small amount of drift with the respective lineages, i.e. any lineage diverging on the O branch would show a signal. Thus, interpreting isolated D- or f4-statistics is dangerous. Fitting many f4-statistics in the admixture graph framework looks more promising, however admixture graphs have a large set of other issues.

      I mentioned this problem with f4/D-statistics in a recent preprint:

      https://www.biorxiv.org/con...

      SI, page 22 (+Fig. S23)<br /> "These results are not unexpected, and it is known that D- or f4-statistics cannot be interpreted unambiguously. Statistics of the type D(Reference, Target; Source, Outgroup) are often used to test for gene flows, and very often distant outgroups (e.g., Africans) are used. However, our results show that for the test to be interpretable unambiguously the ancestry components need to be perfectly balanced in the reference and target, which is hard to control in high-throughput analyses. Moreover, there is a higher chance of encountering gene flows into the reference group if genetically distant outgroups are used since many lineages that could contribute gene flows could diverge on the outgroup branch."

    1. On 2022-01-31 20:35:11, user Tomás Matus wrote:

      This preprint has been accepted for publication and the citation is as follows:

      Orduña, L., Li, M., Navarro-Payá, D., Zhang, C., Santiago, A., Romero, P., Ramšak, Ž., Magon, G., Höll, J., Merz, P., Gruden, K., Vannozzi, A., Cantu, D., Bogs, J., Wong, D.C.J., Huang, S.-s.C. and Matus, J.T. (2022), Direct regulation of shikimate, early phenylpropanoid and stilbenoid pathways by Subgroup 2 R2R3-MYBs in grapevine. Plant Journal. doi:10.1111/tpj.15686

    1. On 2018-12-13 18:00:39, user Jon Moulton wrote:

      I was too quick to assert that it is the loss of the knocked-down protein that causes the p53 response and likely the stress response as well. Didier Stainier has a recent preprint describing triggering genetic compensation by fragments from the nonsense-mediated decay pathway. It is possible that it is not the loss of a protein but instead is the product of RNA decay that acts as the trigger for the p53 or stress responses as well, though this preprint describes only the compensation response to RNA fragments. (El-Brolosy et al. Genetic compensation is triggered by mutant mRNA degradation. bioRxive. 2018. doi:10.1101/328153)

    1. On 2020-07-04 13:20:20, user David Curtis wrote:

      rs11385942 is very much commoner in South Asians than Europeans:

      https://gnomad.broadinstitu...

      Given this fact, how sure can we be that the GWAS hits you cite are not simply an artefact due to failure to properly control for population stratification? The second study you cite has not published the results you rely on in a peer-reviewed journal - the citation just points to a description of the initiative.

      When I see hits like this which arise from a variant with markedly different allele frequencies in different populations my natural reaction is to suspect an artefact.

    1. On 2015-09-21 10:20:58, user Markus wrote:

      Dear authors,<br /> Thank you for this very valuable resource and interesting<br /> work. For me it is not completely clear how to interpret the differences<br /> between the sequencing depth mentioned in the second sentence of the results<br /> section and the sequencing coverage in figure1 and table S1. The numbers<br /> strongly deviate from each other.

    1. On 2019-12-30 18:12:36, user Fraser Lab wrote:

      The major goal of this paper is to use diffuse scattering data to inform models of collective protein motions. This is a landmark paper that unites many disparate observations in the field and pushes the state of the art forward much more so than any paper since Wall et al, 1997 PNAS.

      Through careful data collection, the authors are able to separate Bragg and diffuse scattering. The major experimental advance over previous work is that their fine-scale analysis enables them to integrate diffuse halos surrounding the Bragg peaks. This data yields the observations needed to model lattice dynamics. They find that lattice dynamics explain a significant fraction of the diffuse scattering data. Nonetheless, the authors noticed residual B-factors and turned to internal protein motions to explain the remaining disorder, which leaves signals both around the Bragg peaks and in hazy streaks and clouds between them.

      To explain these residual features, they tested both normal modes analysis (NMA) and full molecular dynamics (MD). Furthermore, they were able to use Patterson analysis to choose between redundant NMA models, conquering an outstanding challenge in the field of macromolecular diffuse scattering. Surprisingly, the NM model that accounts for lattice motions and internal protein motions matches the data better than a crystalline MD model. What does this mean for MD that a reduced representation fits better?

      Overall, the data collection and processing are extremely thorough. Opening up these analytical methods to the community is the next step - and publishing their code is the only essential revision we would request prior to publication.

      Despite our enthusiastically positive interpretation, we do have a few minor questions and requests for clarification:

      While examining the exponential decay in halos around the Bragg peaks, why are the 100 most intense peaks between 2 Å and 10 Å focused on? In Figure 2 it appears that there is a skew in the distribution of exponents toward a sharper decay (n > 2). How do the histograms look when more halos are sampled? Is it possible that this sharp decay could be explained by Bragg peaks that are leaking into adjacent voxels?

      The authors are rigorous and explicit in their modeling efforts and make impressive strides forward. Still, we are left with questions about these models. For refinement of the lattice dynamics model, a small fraction of halos were chosen. Why did the authors not use all the halos? Why was the angular range of 2 Å to 2.5 Å chosen for refinement? Why does this resolution range differ from the analysis of halo decay ( 2 Å to 10 Å)?

      As we commented above, we were surprised to see that a NMA model matched the diffuse intensities better than a crystalline MD model. We wonder whether incorporating the isotropic component of the diffuse scatter would alter this interpretation? Furthermore, since the authors scrupulously subtracted sources of isotropic background scatter, why was the remaining isotropic portion of diffuse scattering not used for refinement of the NMA and MD models?

      Using diffuse scattering data to distinguish between competing models of motion has been a longstanding challenge in the field of macromolecular diffuse scattering, and we are impressed with the authors’ work in this regard. This is really a breakthrough! We were surprised to see how subtle the effects of restraining domain motions were upon the ?PDF in Figure S17, can the authors comment on the statistical significance of this difference? What is the uncertainty in the Patterson map, and how does this play into the interpretation of the best model?

      We have no major stylistic recommendations. The figures are elegant and clearly represent the main points of the paper. Similarly, the text is clear and concise, with thorough expansion in the supplemental material.

      On a final note, this paper pushes the field forward, and we believe there is room for further speculation. A few areas to consider:<br /> How might crystallographers who encounter more mosaic Bragg peaks (these are some of the least mosaic crystals in existence!) separate the Bragg signal from the diffuse signal to analyze halos? <br /> In what ways can NMA models and MD be further improved to match diffuse scattering data? <br /> What complications might arise in crystals with more complex unit cells, and how can this be overcome? <br /> How do they reconcile the results of ref 18 with their analysis of the lattice dynamics (different systems obviously)?

      The authors have done an excellent job of carefully collecting data, thoroughly analyzing it, and clearly explaining their work. We think that digging into the questions above may add to the already substantial impact of this paper, and look forward to their replies. Nonetheless, we think this important paper is worthy of publication as is (noting the caveat of code release).

      We review non-anonymously, James Fraser and Alex Wolff (UCSF)

    1. On 2020-12-01 23:43:34, user Adrian Barnett wrote:

      This is a useful experiment given the shortage of experiments into funding. As Guthrie et al (reference #1) stated: "We need to overcome the reluctance of funders and scientists to acknowledge the uncertainties intrinsic to allocating research funding, and encourage them to experiment with peer review and other allocation processes". The results are broadly supportive of a simpler and cheaper peer review system.

      The agreement between reviewers was not adjusted for chance (e.g, using Gwet’s statistic). I agree with this approach as the raw agreement is what researchers are interested in (their only question is always, “Was I funded or not?”). We can account for chance by setting a threshold for an acceptable difference, e.g., an agreement of 75%. This threshold would ideally be based on discussions with the research community.

      The differences in agreement were tested using chi-squared, but these are paired categorical data and so I think McNemar's test would be better. Although I'm not sure that p-values are useful given the sample size and the potential for a p-value of 0.05 to be interpreted as demonstrating equivalence. I would focus on the confidence intervals and whether they rule out an important difference in agreement.

      The authors use Wald intervals but the sample size is small and the proportion is sometimes close to one, hence the normal assumption may start to be strained. I would consider using a bootstrap interval.

      Although face-to-face meetings for peer reviewers may increase trust they also are a networking opportunity and could disadvantage those not invited or unable to attend (e.g., researchers caring for children). It is also a great learning opportunity for the reviewers about what makes a good application.

      Minor comments<br /> - Table 1 shows summary statistics not "the distribution" <br /> - "no negative or positive reactions to the use of random selection were received from applicants" but was feedback asked for or were there only unsolicited comments?<br /> - The success rates here are very high success rate compared with other schemes. This may put less pressure on the system and allow it to conduct more novel experiments such as modified lotteries.

    1. On 2021-01-20 17:53:06, user Patrick Jodice wrote:

      *error in abstract* should be 54,700 km of surveys, not 54.7 km. 50 km would not have been much of an effort : ) <br /> Apologies to my coauthors for not catching that prior to submission.

    1. On 2018-07-12 23:18:28, user Haoyang Zeng wrote:

      Thank you for your work. I'd like to point out that for class II MHC, comparing your AUCs with what netMHCIIpan3.2 reported is not fair. In netMHCIIpan papers (from 1.0 to 3.2), the authors partitioned the data into a five folds in a way that each fold is far away from the other folds in sequence space in order to minimize over-estimation of predictive performance (see the netMHCIIpan3.1 paper and the other older versions). This could be the reason that their AUCs are lower than yours which were obtained from a random partition of training/test set.

      They authors's recent publication provides a platform to train their model on any dataset (http://www.cbs.dtu.dk/servi... ). You might want to train netMHCIIpan on the same dataset to have a solid comparison. Hope this helps :)

    1. On 2024-04-16 19:58:42, user Marie-Alda Gilles-Gonzalez wrote:

      The much higher affinities you report do not agree with the Wayne model of Mtb. How did you purify your DosT and DosS proteins? Since you are impugning our work, and it does matter very much how the proteins are purified, you should provide information on this. Were your DosT and DosS fusion proteins? Were they tagged? If so, how and where?

    1. On 2018-07-03 11:35:43, user Froylan Calderon de Anda wrote:

      Why you are not citing the published work related with TAOK2 and neuronal development? There are at least five papers which should be cited (Calderon de Anda et al, Nature Neuroscience, 2012; Yadav et al, Neuron, 2017, Ultanir et al, Neuron 2014; Yasuda et al, Neuron; 2007; and Richter et al, Molecular Psychiatry 2018). <br /> You wrote: "First, extensive heterogeneity and incomplete penetrance of the associated phenotypes adds additional challenges to genetic mapping strategies that use atypical variants. Second, while this deletion is enriched within various neurodevelopmental disease cohorts, exome sequencing studies of hundreds of individuals have not identified any individual genes within this region as causative for these diseases on their own. Third, functional studies using cellular, mouse, and zebrafish models have implicated several different genes within 16p11.2 in neurodevelopmental phenotypes"<br /> However, none of the listed papers above are cited.

    1. On 2017-01-14 16:39:55, user Peter Hohenstein wrote:

      I like this manuscript and although the modeling and mathematics behind it is way over my head, I think this is a good approach to get new insights and testable hypotheses.

      I think I can understand the importance of combining potentially several different factors into a single generic one for modelling purposes. However, I would suggest not to call this 'GDNF' or any other existing factor. I think by doing this the subtlety of this being potentially (and I think likely) the combined effect of multiple factors (even though this clearly is explained) will be lost, and pretty soon this will be seen as a GDNF model, not a generic model. Using a non existing name would easily prevent this confusion from arising... Just a thought of course... :-)

    1. On 2014-06-10 13:49:57, user Authors of the manuscript wrote:

      Dear Mike X Cohen,

      this kind of personal commenting is much more helpful and constructive for the authors than the anonymous peer-review process and we thank you for taking your time to write this comment. We respond to some of your points in the following:

      MXC: “It is not always clear whether the authors are criticizing the biophysical interpretation of CFC analyses, or the mathematical foundations of CFC methods. Perhaps it would be useful for the authors to define the situations under which CFC could be validly interpreted, and what exactly the neurobiologically meaningful interpretation would be.<br /> Concerning the former, the authors accurately state that relatively little is understood about the neural mechanisms that could produce CFC, and this may impede interpretations of empirical findings (the same criticism applies to most macroscopic measures of brain activity, including ERPs, time-frequency power, most measures of functional connectivity, the FMRI BOLD response, etc.).”

      Authors:

      We agree with this comment in the sense that indeed many measures in Neuroscience depend on an interpretational step. However, in contrast to the current handling of CFC, these aspects are well acknowledged for measures like BOLD and ERP. In addition there have been intense efforts to disentangle various generating mechanisms of BOLD signals and ERPs. (For the origin of the BOLD signal, the role of astrocytes, lactate, and calcium see for example: Niessing et al, Science, 2005; Logothetis et al., Nature, 2001; Barros, TINS, 2013; Petzold&Murthy, Neuron, 2011; Iadecola&Nedergaard, Nat Neurosci, 2007 . For generating principles of the ERP see for example: Mazaheri & Jensen, J Neurosci, 2008; Turi et al. NeuroImage, 2012; Telenczuk et al, J Neurophysiol, 2010, and references therein).

      In these fields, the variety of generating mechanisms is typically discussed and wording is carefully chosen. With respect to the interpretation of CFC measures, this care is often lacking. Moreover, the mathematical methods of CFC are more involved compared to standard BOLD-fMRI or ERP analyses. Therefore, plain technical errors in published work occur more frequently than in either ERP or BOLD fMRI studies.<br /> _____

      MXC: “Their suggestion for researchers to label their CFC analyses as relatively exploratory vs. confirmatory and as a marker vs. biophysical understanding (figure 5) is also sensible (this suggestion also could be applied to most or perhaps all measures of brain activity). The reliance on DCM should be cautioned against the over-parameterization and opaqueness of DCM models used in practice.”

      Authors:

      We agree with this comment insofar as the mathematics involved in DCMs is necessarily much more involved than that in the current standard CFC analyses. In our opinion however, this is outweighed by the advantage to be able to state the relative odds for and against the presence of a CFC mechanism in the data. Moreover, we also agree that the mathematical complexity of model specification indeed results in a certain opaqueness, especially to the lay.

      We disagree with the criticism of over-parametrization, as models selected by Bayesian model comparison need two properties: (1) the ability to explain the data well, and (2) generalizability. The latter is ensured by automatically favoring models that explain the data well without using an excessive number of parameters, thus implementing Occam's razor. However, it is indeed necessary to carefully specify models for comparison, that are plausible a priori, based on existing knowledge (Lohmann et al, NeuroImage, 2013; comments by Friston et al, NeuroImage, 2013; Breakspear, NeuroImage, 2013; reply by Lohmann, NeuroImage, 2013). This requirement may mean that DCMs of CFC will have to wait until the mechanisms underlying CFC are spelled out more explicitly using interventions.<br /> ____

      MXC: “the general point is that methods for assessing CFC are not necessarily confounded just because their results can be difficult to interpret from a neurophysiological perspective. Let me explain this by analogy: Imagine comparing ten randomly selected negative numbers with ten randomly selected positive numbers. A t-test would indicate statistical significance, but this significance is uninterpretable. However, the reason that the result is uninterpretable is not due to a confound of the t-test, but rather, due to the assumptions underlying the data collection. Imagine you received the same numbers but were told that they reflected measurements of relative alpha-band power in conditions A and B. Now the same result would be interpretable.”

      Authors:

      Indeed, in some sense the whole first part of our paper illustrates the variety of different but equally plausible reasons behind a CFC signature, or different possible interpretations if you wish. So, why do we call them "methodological confounds"?

      Taking an analogy with the t-test might help us here, though we think that the analogy provided by MXC is slightly misleading and prefer a different version of the analogy. Namely, when you make a t-test, the un-interpretability is not only about the "origin of the data" (as in the example of MXC), but also (and actually even more) about the "nature of the data".

      T-test makes specific assumptions on the underlying probability distribution (e.g. normality) and when these assumptions do not hold, the p-value obtained might very well just reflect the fact that the underlying distribution did not match well.

      This is similar to CFC - we do not claim that the CFC measures are wrong, but in some sense show that the underlying assumption that there is real coupling in the data might well be doubted (for several reasons explained in the text). We show how alternative assumptions (i.e. non-linearity, common drive etc) could as well account for high CFC values. I.e. the CFC measure describes the amount of coupling only if we already assume the existence of this coupling, and the absence of the other mechanisms, or their constancy over experimental conditions.

      Maybe "methodological confounds" sounds more appropriate if one keeps also this analogy in mind - if the methodology is applied in case of doubt with assumptions, the results are not interpretable. It is the same with the T-test - applying it to any distribution, one is not able to draw conclusions. This is not a fault of the T-test. However we would end up with a possible confound if we DID not know what the underlying distribution is, but still applied the T-test. In the case of CFC analysis we do not have a good understanding of underlying biophysics, but still apply the CFC measure and try to interpret it.

      It might be useful to compare two different possibilities of expanding the acronym CFC - either Cross-Frequency Correlation or Cross-Frequency Coupling. The latter indicates biophysical interaction and even causality and is the one used now in the literature. Our article discusses at length why in fact we should rather hold to Cross-Frequency Correlation. Moreover, we explain that even in this case it is important to try to partial out the effects that could diminish the specificity of CFC as a marker.<br /> ______

      MXC: “Their first example is the van der Pol oscillator. The authors claim that CFC here reflects a confound, because (page 3) “there is no simple physical interpretation for the different frequency components of the oscillator.” The interpretation depends entirely on the assumptions of the signal. If this were a neural signal, one might interpret that certain phases of the lower frequency oscillation regulate the variability of faster activity (as an aside, the lack of band-limited activity in Figure S1 is a classic situation of when *not* to interpret results as reflecting an oscillation; this has been discussed since the 1990’s by, among other researchers, Singer, Tallon-Baudry, Pfurtscheller, Miller). This is readily apparent by plotting the van der Pol signal along with its rectified derivative, which can be obtained with the Matlab code below:

      ode = @(t,y)

      vanderpoldemo(t,y,1);

      [t,y] = ode45(ode,[0 20],[2 0]);

      plot(t,y(:,1)), hold on

      plot(t(1:end-1),abs(diff(y(:,1)))*8,'r')

      The problem here is not with the measure of CFC. In fact, I do not see a problem at all; the authors simply tested a method on simulated data and got a result, much like a t-test on signed random numbers would produce a result. Here is another, even more striking, example:

      t=0:1/1000:1;

      plot(t,sin(2*pi*40*t) .*sin(2*pi*t))

      As with the van der Pol illustration, one can say that CFC here is uninterpretable because there is no interaction amongst subsystems; there is simply a 40-Hz sine wave multiplied by a 1-Hz sine wave (this could occur from two independent systems with wave cancelation at the recording electrode). Again, the problem is not with the CFC measure, but that the simulated data do not lend themselves to a neurobiological interpretation of CFC.”

      Authors:

      Indeed, “the simulated data do not lend themselves to a neurobiological interpretation of CFC”, and neither do the neurobiological data at the moment. This is one of the main points of the manuscript.

      The problem is that for now, the neurobiological measurements might not lend themselves to the “coupling” interpretation of CFC. The CFC analysis has been adopted and is used with a certain aim and interpretation. Thus it seems fair to say that if the methodology does not provide answers and interpretations it should, we deal with "methodological confounds".

      The examples brought up show that without further assumptions and knowledge of the underlying neurobiology, current methodology is unable to discriminate between various basic but very different interpretations. In analogy with the T-test example above, similar other toy examples treated with a T-test would illustrate what could happen if the underlying distribution did not match the assumptions (i.e. normality) - and why a T-test is not applicable without checking its assumptions first.

      As we mention in several places, this is not a problem when one tries to use the CFC measure only as a MARKER, however the problem comes when one goes one step further in the interpretation, trying to give a particular (physiological) meaning to CFC (“high frequency oscillations modulated by low frequency phase” or something along these lines).

      Also, notice that your second example (modulated sinusoids) does tell you something about which parameters (in terms of bandwidth) should be used so that the CFC measure would be closer to its desired interpretation.<br /> ____

      MXC: “Their other examples are also not compelling as identifying any confounds with CFC measures. Prime numbers are nonrandom sequences with a periodic structure (http://xxx.lanl.gov/pdf/cond-m... and anyway, true random sequences can appear non-random at small N. A more serious concern is that the authors are interpreting CFC in random data or in ECoG data with non-linearity introduced (Figure S6) without performing any statistics to justify the interpretation of CFC. Analogously, a t-statistic on random numbers is unlikely to be exactly 0; it is only through evaluation of that t-statistic with respect to a null hypothesis distribution that a t-value of, say, 1.5 can be interpreted.”

      Authors:

      Interestingly enough, prime-numbers, when one partials out the fact that there is only one even prime number, one prime number that is divisible by three etc, seem to be best described as what are called pseudo-random numbers. (See for example any of Terence Tao’s blog posts or presentations on “primes and pseudorandomness”.) So at least for now, to our knowledge, there seems to be no reason to believe that there is cross-frequency coupling behind any process we might expect to generate prime numbers. ;) But of course this is just an illustration of how hard it is to conclude anything about mechanistic processes by just using a CFC measure. As a side note, one should also not forget that still some care is needed when interpreting such statistics, i.e. recall the numerical information on the change of sign between \pi(x) and li(x) and Skewes’ numbers. ;) But probably none of us is an expert on primes and knows exactly why they give rise to a high CFC index. We reason in the article that even in the case of the CFC measured from the brain, this “why” still continues to have a multitude of possible answers.

      Now, more seriously, in the ECoG or random data we use the exactly same procedure as is usual in the CFC analysis. Indeed, we used the code provided by Tort for the modulation index, and the code provided by Canolty et al. from their Science paper and hence, their respective surrogate analysis (and in our text it was indicated that the results were significant). In addition, for the non-linearity case we even provided a simple example (supplementary material) where we derived analytically that quadratic non-linearities lead to CFC. <br /> ____

      MXC: “Another issue identified by the authors is the potential confound of co-occurring but independent low-frequency phase and high-frequency power dynamics. This is a potential confound (discussed in Cohen, 2014, Analyzing Neural Time Series Data; figure 30.7) but is fairly easy to identify and address (including: avoiding interpreting CFC from immediate post-stimulus periods, removing the phase-locked time-domain signal before computing CFC, and inspecting whether the time-course of CFC differs from the time-course of phase clustering). Perhaps the authors have additional suggestions?”

      Authors:

      As we note in our manuscript “if a brain area under a recording electrode receives time-varying input from any other brain area, this input might generate similar dependencies across frequency components (Figure 4A). The problem is that usually one has no control over the timing of the internal input to the examined brain area (Figure 4B). Thus, phase-amplitude coupling measured anywhere in the brain can be potentially explained by common influence on the phase and amplitude, without the phase of a low frequency oscillation modulating the power of high frequency activity.” The improvements mentioned in your commentary do not help to identify and address the problems with INTERNAL input, where we have no idea about the onset time (see Figure 4). <br /> ____

      MXC: “Later, they write (pages 9-10 and figure 4) "If a brain area under a recording electrode receives time-varying input from any other brain area, this input might generate similar dependencies across frequency components." This does not seem to be a confound, but rather, a description of CFC: low-frequency oscillations from a distal brain region modulate local activity, as manifest in higher frequency oscillations. Perhaps if the authors would identify a mechanism/consequence of CFC for neural activity it would be easier to understand whether/how this is a confound.”

      Authors:

      There is a misunderstanding here. We would not NOT agree with the interpretation that “low-frequency oscillations from a distal brain region modulate local activity, as manifest in higher frequency oscillations”. Instead we clearly write in our manuscript that “non-stationary input to a given area simultaneously affects the phase of a low frequency component and increases high-frequency activity (common drive to frequency components of the same signal).” This means that the low frequency phase is modulated and the high frequency component is influenced by the same common drive to the area. As we conclude: “In this case, high-frequency amplitude increases occur preferentially for certain phases of slow oscillations even without any need of interaction between the two rhythms.” (See also Figure 3). Again, we would agree on this point if CFC would stand for Cross-Frequency Correlation rather than Cross-Frequency Coupling, as the latter indicates interaction or causality.

      ____

      MXC: “On page 6, the authors write “The main conclusion is – not that surprisingly - that a clear peak in the power spectrum of the low frequency component is a prerequisite for a meaningful interpretation of any CFC pattern.” The justification does not follow. If one is interested in *phase* dynamics, why does there need to be a peak in *power*? Assuming that phase reflects the timing of neural populations while power reflects their spatial coherence at the LFP level, why is spatial coherence considered a prerequisite for investigating timing? In real EEG data, power and phase dynamics are often independent of each other.”

      Authors:

      It is here not at all necessary to think about which neural processes the phase or power variable could reflect. The reason for why a peak in the power spectrum is a prerequisite for a meaningful interpretation of phase (as an index that is a parameter of an oscillation) is well known in the physics/electrical engineering community and simply comes from the signal processing perspective: phase can be meaningfully defined only for narrow-band (and slowly frequency-varying) oscillatory signals for which the phase grows monotonically (please see page 35 of the manuscript: Supplementary discussion - conditions for a meaningful phase). Note that although narrow-band filtering a signal enhances smooth dynamics of its phase, it does not improve its physical interpretability.

      ____

      MCX: “A related discussion is potential differences in power across conditions. CFC methods generally measure the relationship between power and phase, not the magnitude of power. Appropriate permutation-based statistical corrections will account for differences in the magnitude of power (Cohen, 2014, chapter 30).”

      Authors:

      Yes, we agree that this is something that one indeed can control for and just point out that this is not always done in the literature. (See literature review).<br /> ____

      MCX: “The potential confound of low power for estimating phase (Muthukumaraswamy & Singh, 2011) applies only for very low SNR; in real EEG data, power and phase dynamics are often easily disambiguated and unrelated to each other.”

      Authors:

      The level of SNR for EEG is dependent on the frequency band considered and stimulation elicited by the experimental protocol. Here the main point is that many studies compare CFC between conditions that elicit very different power in a given band (e.g. peak vs no peak). Thus there is straight away a bias in the reliability of the phase estimation and therefore of the phase-amplitude coupling. How big this effect is should be assessed for each dataset. In addition, the amplitude and phase defined by the analytical signal approach (using Hilbert transforms) are not fully independent and even a nominal change in one of them induces a perturbation in the other (Supplementary Figure 7B).

      ____

      MXC: “Table 1 should include citations of the papers surveyed; otherwise independent verification is not possible.”

      Authors:

      we feel that the description preceding the literature review enables anyone to find the respective papers (as the years, journals and search criteria have been mentioned, a simple PUBMED search can provide the explicit list of papers considered). The magic paper is the one we added manually, which we indeed can identify here - Saalmann et al., 2012 in Science. The literature review covers papers up to January 2014 (included).

    1. On 2025-08-04 18:32:32, user Leslie Biesecker wrote:

      Wonderful work. I wonder if you should replace most, if not all, occurrences of the word "conserved" with a form of the word "identical". "Conserved" (in the protein context) can mean identity or similarity, the latter being a more elastic term, that can depend on which matrix you choose and then your definition of the degree of similarity that you determine to meet your definitional threshold. Reading this preprint, I have the feeling you mean identical amino acids when you say conserved amino acids. Or maybe "conserved" means similar and "fully conserved" means identical? Would be great to clarify this. <br /> Note that we use likelihood ratios to calibrate evidence for clinical variant classification, not sensitivity and precision. In your first pass you had 4,328 & 26,006 for the P/LP variants and 245 & 16479 for the B/LB. That yields LR+ of 1.55:1 and 1/LR- of 7.25:1. That would not meet the supporting criterion (+1 Bayes conditional probability points) for pathogenic evidence. It would meet moderate evidence (-2 Bayes points) for benign evidence. When you increased stringency, you got 3,884 & 26,450 for P/LP and 102 & 16,622 for B/LB. That again does not meet the supporting threshold for pathogenic evidence (1.6:1) but it does strengthen the benign evidence with 1/LR- or 15:1 (between moderate and strong, -3 points). Not sure I am doing the math correctly from your data - feel free to correct me if I am wrong about this.

    1. On 2016-03-18 13:55:54, user Fabien Campagne wrote:

      Interesting visualization work. I think in addition to the stated aim, but from my point of view potentially as important, is the visualization of workflows under execution. Developing workflows would be helped by looking at such plots annotated with timing info, or success failure conditions, because the workflow may not work right away and better development tools would make the process easier. I think aggregation of provenance data, if error conditions are captured would be very useful as a workflow development and debugging help.

      It this is of interest, please contact me, we are looking for good ways to visualize workflows as they are executing/being developed. See GobyWeb (http://arxiv.org/abs/1211.6... "http://arxiv.org/abs/1211.6666)") and its successor, NextflowWorkbench (http://biorxiv.org/content/... "http://biorxiv.org/content/early/2016/02/24/041236)").

    1. On 2020-04-14 07:03:59, user Torsten Seemann wrote:

      This paper uses "Snippy" for variant calling, which I wrote, on FASTQ data I and others produced. The authors may not realise that the reads are not WGS but amplicon sequencing and need appropriate primer trimming to avoid false SNPs.

    1. On 2025-04-17 11:02:02, user Eva-Maria Geigl wrote:

      Comment from Olivier Putelat:

      In this study, a cat mandibule is used as a reference to which other mandibles are compared. It is named « the felid from Iron Age Entzheim, France ». <br /> Apart from the absence of any citation of the analysis of this specimen that needs to be introduced, there are several scientific problems in the way it is used:

      1. It is not clear which specimen was used in this analysis. No measurements are indicated in tables S3 and S4 and the specimen is used in Fig. S2 simply named « the felid from Iron Age Entzheim, France », but there are two mandibles that I analyzed: one comes from site 4752 Entzheim-Geispolsheim "Aéroparc-Lidl" excavated in 2006 and the other from site 5046 Entzheim-Geispolsheim "Lotissement d’activités Entzheim 4" excavated in 2008. As the authors of the present study did not contact me, they did not have my measurements. Therefore, it is not clear how the indicated measurements were taken and on which specimen.

      2. In legend of Fig. S2 « A) Mandible and B) cheektooth row lengths (P4 - M1) (numbers upper case) » are problematic. First, as it is a mandible, these measurements should be indicated as (P4 - M1) (i.e., numbers as lower case) and not as (P4 - M1) (numbers as upper case). Second, it is unclear why the authors measured (P4 - M1) and not (P3 – M1), as they did in table S4 and for the axis of Fig. S2B. Finally, the length (P3 – M1) is shown as to be ~24,5mm, while the measurements of this trait I took on the complete mandibles before sampling for the paleogenetic study (published in 2017) are very different.

      Therefore, these various issues must be corrected.

    1. On 2019-10-08 19:06:57, user QuiPrimusAbOris wrote:

      Such clone tracking tools will become more and more important with the spread of single-cell transcriptomics and accessibility of more sophisticated cell cultures, including organ-on-chip. It will bring snap-shot analyses, such as scRNAseq, into the realm cell fate histories tracking. There are many similar tools in the pipelines of academic and industrial labs. Surprising that there is so little discussion (and comparison) of prior similar art. Such a discussion would have been very useful.

    1. On 2022-02-28 21:28:13, user Joseph Wade wrote:

      The following is a review compiled by graduate students participating in the Infectious Disease Journal Club, Department of Biomedical Sciences, University at Albany, SUNY:

      This paper addresses the significance of cis-regulatory elements in the expression of the Type Six Secretion System (T6SS) of Vibrio cholerae. Previous work has shown that the transcription factors QstR and TfoY are key regulators of the V. cholerae T6SS in a pandemic strain, but the authors demonstrate constitutive expression and activity of the T6SS in other V. cholerae strains that have a single SNP in the intergenic region upstream of the T6SS genes. This work has important implications for how T6SS expression has evolved in different V. cholerae lineages, and the conditions under which the T6SS is active in different strains. More broadly, the paper demonstrates that a single SNP in an intergenic region can dramatically affect gene expression.

      The data are of high quality throughout the paper, and the use of complementary assays of T6SS activity and expression provides independent assessment of T6SS regulation. The major conclusion of the paper is that a T at position -68 is associated with strong expression/activity of the T6SS, whereas a G at -68 has much lower T6SS expression/activity unless qstR is overexpressed. This conclusion is well supported by the data. However, the authors also argue that having a T at position -68 makes T6SS expression independent of QstR, but they do not test this. It may simply be that a T at -68 leads to overall higher expression of T6SS genes that could be further boosted by overexpression of qstR. Whether or not T6SS expression is affected by QstR in strains with -68T has important implications for the mechanism by which position -68 influences T6SS expression.

      Major Comments:

      1. The authors claim in several places that the base identity at position -68 determines whether or not T6SS expression is activated by QstR. However, the authors do not test whether overexpression of qstR (i.e., the qstR* strain) impacts expression of T6SS genes in strains with a T at -68. For some strains, expression may already be so high that any effect of qstR overexpression will be difficult to see, but that is likely not the case for strains VC22, 2479-86, and 2512-86. The authors should test the effect of overexpression of qstR on T6SS expression or activity in one or more of these strains.

      2. The paper implies that QstR expression is induced by chitin. This connection should be more clearly explained. If QstR expression is indeed induced by chitin, an important additional experiment would be to show that chitin promotes T6SS expression/activity in C6706, and that this effect is reduced in a ?qstR strain.

      Minor Comments:

      1. We recommend quantifying the data shown in Figure 1G and moving this to the supplement. Alternatively, Figure 1G could be removed from the paper since it is largely redundant with Figure 1C.

      2. It would be helpful to modify Figure 3A to include the phylogenetic tree from Figure S3.

      3. Position -68 is sometimes referred to as -388, presumably reflecting the position relative to the start codon of the first gene in the operon. We recommend using “-68” throughout.

      4. One of the data points in Figure 2B/C is labeled as “IGRV52”. While this is correctly labeled, we suggest changing the label to “G-68T”, as this makes the figure easier to interpret and easier to compare to Figure 2D/E.

      5. There are published ChIP-seq data for QstR. It would be informative to briefly discuss where QstR binds relative to position -68. This could be indicated in Figure 2A.

      6. The discussion is very brief. We encourage the authors to elaborate on (i) possible mechanisms by which the SNP at position -68 alters T6SS expression, and (ii) possible selective pressures associated with the SNP at -68 for the different V. cholerae strains.

      7. A figure at the end of the paper showing a model for the two types of regulation would be helpful for readers. This schematic could include what we already know about the roles of TfoX, TfoY, and QstR in T6SS regulation.

    1. On 2025-05-01 14:52:55, user Alireza Soltani wrote:

      Despite the claim of the authors, two published studies have used autoregressive models to estimate timescales of neural activity: <br /> 1. Spitmaan, M., Seo, H., Lee, D., & Soltani, A. (2020). Multiple timescales of neural dynamics and integration of task-relevant signals across cortex. Proceedings of the National Academy of Sciences, 117(36), 22522-22531.<br /> 2. Trepka, E., Spitmaan, M., Qi, X. L., Constantinidis, C., & Soltani, A. (2024). Training-dependent gradients of timescales of neural dynamics in the primate prefrontal cortex and their contributions to working memory. Journal of Neuroscience, 44(2).

    1. On 2020-05-15 18:23:57, user Patrick Allison wrote:

      "Although the initial Abbott package insert had stated that 0.5 to 3.0 mL of viral transport media was acceptable for use in their assay, "

      It looks like it was the initial packaging insert that was flawed.

    1. On 2018-02-21 16:07:49, user Robert E White wrote:

      Please note that a revised and updated version of this paper has now been peer reviewed and published in PLoS Pathogens:<br /> Szymula A, Palermo RD, Bayoumy A, Groves IJ, Ba abdullah M, Holder B and White RE. (2018) Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.<br /> PLOS Pathogens 14(2): e1006890. https://doi.org/10.1371/jou...

    1. On 2021-06-30 17:10:28, user Mehmet wrote:

      First of all this is a very informative manuscript that provides insights how a single amino acid is responsible for pathogenicity. I found some minor typo errors. Additionally, have authors performed a FDR test over p-values of LRT results?

    1. On 2021-03-22 10:49:36, user caelum forder wrote:

      News articles are reporting this as the virus can't be killed at boiling temperature. The highest temperature they tested was 92C, and I find it very interesting that is the highest results they show. I feel like they omitted higher temperatures because it killed the virus very quickly and they wanted to make the research look meaningful. If you are reporting this paper, PLEASE do not refer to 92C as boiling water. People will think that boiled kettle water isn't safe, when in reality it will be hotter than 100C

    1. On 2017-01-12 13:40:51, user Devon Ryan wrote:

      Feedback from presenting this in a journal club:

      1) Can you include Corset in the DE comparisons?<br /> 2) Can you demonstrate how well this does with paralogs? I know that this is discussed in the methods, but there aren't any results shown regarding it. This ends up being important in immunology, where there are a number of interesting sets of paralogs.

    1. On 2018-12-04 21:43:20, user Mahmuda Sultana wrote:

      As a student of Life Science Informatics, I have found this article very useful for me. It nicely explains the importance of FAIR principle along with the history of data life cycle in present and past as well. Importantly, it emphasizes on data storing and sharing for long-term purpose, that attracts me very much. However, you mentioned about Data Management Plan, and I would like to ask you, is it the same like, NFS Data Management Plan or it is a different approach from you?<br /> Thanks for such a great work!

    1. On 2018-12-14 04:16:23, user Davidski wrote:

      Hello authors,

      I see that you're still using the ethnic Poles from Estonia in your analyses.

      Please refrain from doing so, because many of these samples are not representative of the Polish population, in large part because they have significant ancestry from Siberia. Surely it would be more useful to represent the Polish population with samples native to Poland that lack this type of unusual ancestry?

      If you do insist on using these unrepresentative Polish samples, then please label them correctly, such as Polish_Estonia.

    1. On 2019-07-26 13:04:56, user Alex Alexandrov wrote:

      Great paper, hi from Alex Alexandrov in Moscow, Russia!

      Question (I might have missed the answer in the paper) - How large a percentage of age-related cell death (division arrest) in WT and mutant strains can be accounted for by terminal missegregation events?

    1. On 2023-12-23 16:13:07, user Quinn Sievers wrote:

      Hello Andreotti lab!

      Quinn Sievers here, postdoc in the Abdel-Wahab lab at MSKCC. I enjoyed reading your paper and found it very informative.

      One comment I had was regarding line 255 of the manuscript where you assess kinase activity of the recombinant T474I and L528W mutants by monitoring Y551 phosphorylation; my understanding was that this site is typically phosphorylated by upstream kinases and that Y223 is an autophosphorylation site and therefore a better measure of kinase activity. I suppose since it was an in vitro assay it was not confounded by the presence of other kinases but I wonder if the Y223 would have shown discordant activity with Y551, particularly for the T474I mutant.

      Best,

      Quinn

    1. On 2020-06-17 09:51:57, user Paul Schanda wrote:

      All the SAXS data and structural models now have an accession number on the SASBDB data base:

      SASDH89<br /> Mitochondrial import inner membrane translocase TIM8-TIM13 in complex with Tim23

      SASDJP4<br /> Mitochondrial import inner membrane translocase TIM9-TIM10 in complex with Tim23

      SASDJQ4<br /> Mitochondrial import inner membrane translocase TIM8-TIM13

    1. On 2020-09-03 04:10:56, user Sunil Dhiman wrote:

      An minimus has beeb important malaria vector in NE India since long. However it was found limited in recent few studies. The study advocates that this vector species A is present in the region, may be in low density.

    1. On 2021-04-16 08:17:18, user Jakub Zahumensky wrote:

      Energy dependence of the existence of gel-like sphingolipid-rich domains has been demonstrated previously. Specifically, Herman et al., 2015 showed that depolarization of the plasma membrane leads to melting of these domains and apparently a more homogeneous plasma membrane. It would be interesting to see if the void zones disappear also following inhibition of Pma1 or using an membrane potential uncoupler, such as FCCP. In presence of PS, there could be a lot of small gel-like domains that coalesce into a big void zone when PS is removed and temperature is elevated.

    1. On 2020-07-02 13:45:06, user Concerned Biophysicist wrote:

      This is very cool work, and the public engagement of folding at home aspect is great to raise awareness/excitement about computational biophysics.

      As a scientists working in the field however, I do wonder if having "to Combat Covid 19" in the title might be crossing a threshold that we as a field collectively decided exists for a reason. Much (most?) of the applied word work in computational chemistry and biophysics is on disease related proteins, and many of the methods we all work on have relevance to drug discovery, so we could all be constantly claiming/marketing most of our papers as "fighting X disease" or "towards a cure of Y diseases" while in reality most of what we do is fundamental basic science, with eye towards pharmaceutically relevant discovery in the future. This science is just as important as applied pharmaceutical research in the research ecosystem, and does ultimately lead to tools and insights that are relevant to the pharmaceutical industry, but I think there is something to be said about keeping some of our powder try in terms of the claims we make about what is essential basic science and what is pharmaceutical research, so as not to create an arms race in the field to market all of our methodological work as having a dramatic immediate effect in curing disease, and end up devaluing and lowering the profile of the essential basic science that makes all this research possible.

      Bluntly speaking, if we all start slapping "to cure cancer" on the titles of every paper that is about developing molecular simulation or drug discovery tools and every paper that studies proteins related to cancer, we may drum up a little buzz and be able to eek some extra press in the short term, but eventually, there is backlash to overselling a field. Other scientists will start to view all of our claims of the value of and potential pharmaceutical relevance of our work as oversold and less credible. This skepticism could creep into funding priorities and funding decisions (for national funding agencies and VCs), so it can effect more than the just the labs that are pushing the boundaries of how boldly we claim that "computational biophysics research = curing disease".

      I get that folding at home is playing a different public facing role in our field than most academic and pharmaceutical/biotech labs, and I think a lot of it is great, but the simplification/boldness of some of the claims does make me worry a bit about an inevitable backlash for the entire field,

    1. On 2017-02-18 20:13:24, user Andy Brower wrote:

      We notice that although you cited Pavel Matos Maravi's critique of our paper, and Valenti

      Rull's critique of our paper, you neglected to cite our paper

      Garzon-Orduna, I. J., Benetti-Longhini, J. E., Brower, A. V. Z. 2014. Timing the diversification of the Amazonian biota: butterfly divergences are consistent with Pleistocene refugia. Journal of Biogeography 41, 1631-1638.

      Nor did you cite either

      Brower, A. V. Z., Freitas, A. V. L., Lee, M.-M., Silva-Brandao, K. L., Whinnett, A., Willmott, K. R. 2006. Phylogenetic relationships among the Ithomiini (Lepidoptera: Nymphalidae) inferred from one mitochondrial and two nuclear gene regions. Syst. Ent. 31, 288-301.

      or

      Brower, A. V. Z., Willmott, K. R., Silva-Brandao, K. L., Garzon-Orduna, I. J., Freitas, A. V. L. 2014. Phylogenetic relationships of ithomiine butterflies (Lepidoptera: Nymphalidae: Danainae) as implied by combined morphological and molecular data. Systematics and Biodiversity 12, 133-147; 259-260 (corrigenda).

      from which many of your outgroup sequences were taken.

      Or

      Whinnett, A., Brower, A. V. Z., Lee, M.-M., Willmott, K. R., Mallet, J. 2005. The phylogenetic utility of Tektin, a novel region for inferring systematic relationships amongst Lepidoptera. Ann. Entomol. Soc. Amer. 98, 873-886.

      which is the source of the tektin primers.

      Does not seem like a coincidence.

    1. On 2020-12-23 01:49:32, user Jingbo Nan wrote:

      Great work! I often see similar intense luminescence during Raman analysis of carbonaceous materials in rocks. I can even get Raman peaks around 1350 cm-1 and 1580 cm-1 (similar to D and G band position) on metal-coated inorganic sample surface, which should be caused by luminescence. It's important to show the whole Raman spectrum in the paper since the luminescence is common.